THE NEW HEALTH CLUB

In this deeply personal episode, I speak with Laura Lewandowski, AI & Business Influencer, founder of the Smart Chiefs Newsletter, TEDx speaker, and one of Berlin’s most insightful businesswomen.She recently embarked on a guided magic truffle journey in the Netherlands. Known among her friends as the “AI Queen,” Laura is a powerhouse in business and tech—but even the smartest and most accomplished among us carry fears and emotional wounds.For Laura, the truffle journey wasn’t just an adventure; it was a process of surrendering control, reconnecting with her body, and finding clarity after a seven-year relationship ended. We explore how this experience helped her:Navigate fears of crying, losing control, and confronting painful emotionsUse inner family systems exercises to map her emotional landscapeReconnect with intuition and her body, leading to insights that influence her personal and professional lifeIntegrate the lessons into her day-to-day life as a mother and entrepreneurSee the power of letting go, and how pain can dissolve into joyKey Moments[00:05:00] Laura shares her initial fear of losing control and how surrender became a doorway to insight[00:12:30] The guided session with two psychologists: setting up her inner family system[00:20:00] How the psychedelic experience revealed disconnection from her feelings and over-reliance on her head[00:28:00] Insights into decision-making, intuition, and the connection between mind and body[00:35:00] Personal reflections on motherhood, prioritizing time with her daughter, and reshaping life and work balance[00:45:00] How embracing emotional waves allows pain to transform into joyWhy You’ll Love This EpisodeThis episode isn’t just about psychedelics—it’s about emotional courage, intuition, and lifestyle transformation. Whether you’re curious about plant medicine, personal growth, or integrating life lessons into everyday routines, Laura’s story offers practical wisdom and inspiration.Links & ResourcesLaura Lewandowski on LinkedIn: https://www.linkedin.com/in/laura-lewandowskiSmart Chiefs Newsletter: https://smartchiefs.beehiiv.com/Learn more about guided truffle journeys on The New Health Club Podcast- https://podcasts.apple.com/us/podcast/dr-julie-holland-psychedelics-make-us-look-at-the/id1474605227?i=1000557560929TakeawaysLetting go of control can unlock deep insights and joyPsychedelic journeys can be a tool for personal growth, emotional integration, and body awarenessIntuition is strengthened when you observe without overthinkingPrioritizing meaningful relationships, like family, transforms how we structure life and work. This episode will be in german, but SPOTIFY allows you now to listen to it in english. Hosted on Acast. See acast.com/privacy for more information.

Hi, today’s guest is Veronika Gold, a therapist and counselor based in San Francisco with extensive experience in psychology. Originally from the Czech Republic, she grew up under communist rule and traveled worldwide before settling in the Bay Area in 2003. She’s passionate about contemplative practices like meditation, mindfulness, and exploring consciousness. Veronica holds an M.A. in Clinical Psychology from Charles University and an M.A. in Integral Counseling Psychology from CIIS. She is involved in MDMA-Assisted Psychotherapy at SF Insight and Co-developed Ketamine Assisted Therapy at New Pathways and Polaris Insight Center. She’s known for her outstanding work and shares her inspiring journey from life under communism to becoming a therapist specializing in transformative trauma work. https://www.polarisinsight.com/the-team/ IG: @Thenewhealthcliub @Thenewhealthinstitue Hosted on Acast. See acast.com/privacy for more information.

Dr. Christopher Timmermann is neuroscientist and co-director of the UCL Centre for Consciousness Research in London. He obtained a BSc in Psychology in Santiago, Chile and an MSc in Cognitive Neuroscience at the University of Bologna in Italy. He was also leading one of the first DMT research groups at Imperial College London.His empirical and theoretical work focuses on the neuroscience, psychiatry, psychology, and beliefs of psychedelics, their relationship to consciousness and applications in mental health. The work he has led has been published in high-regarded journals, and has been widely covered by mass media outlets. He also founded and is the director of an educational non-profit in Chile, the ECOH Foundation.He is the expert on 5MeO DMT right, which has been dubbed the “Mount Everest of psychedelics,” and fittingly, Timmermann writes, “its experiences are often referred to as “whiteouts.” But beyond its ability to eliminate the sense of space and time, its most interesting effect lies in the way it dissolves the self. This is key. The question of whether the self is necessary for consciousness to occur has been debated by philosophers for thousands of years — and it remains unsettled. But with 5MeO, something completely different happens: It radically deconstructs all possible worlds, sparing only awareness.IG: christophertimmermannOUR INFO: IG: @the.newhealthclub @thenewhealthinstitute Website: https://www.thenewhealthinstitute.org/ Hosted on Acast. See acast.com/privacy for more information.

Hadas Alterman is an attorney who co-founded Plant Medicine Law Group, the first psychedelic industry focused law firm. She helped shape the legal psychedelic frameworks in Colorado and Oregon and the professional standards for psychedelic-assisted therapy. She is also working as a the director of legislative strategy for Stand With Us. Our topic today is how we can tolerate and accept very different world views in a conversations. In these times, this seems to be the number one talent we need to come up with human being. So how can psychedelic journeys contribute to this and have us tolerate messy conversations and understand the other camp? Linkedin:https://www.linkedin.com/in/hadasalterman/ Hosted on Acast. See acast.com/privacy for more information.

Dr. Leor Roseman, Senior Lecturer and Psychedelic Researcher at the University of Exeter, has explore this avenue. His study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis” a few years ago, was fascinating.I read about it in 2021, (https://pmc.ncbi.nlm.nih.gov/articles/PMC8170481/) and we recorded the first podcast. To me the idea made a lot of sense. Now, with the urgency amid the current situation after October 7th, his work seems more important than ever. In his scientific work Leor examines how psychedelics can serve as peacemaking tools by altering consciousness through a biopsychosocial lens, incorporating neuroscience, psychology, anthropology, and phenom enology. With a background at the Centre for Psychedelic Research at Imperial College London, under Prof. Robin Carhart-Harris and Prof. David Nutt, Leor was curious how psychedelics now can deliver a new peacemaking tool. His foundation Ripples, a non-profit dedicated to peace building supported by psychedelics, is now researching new ideas around understanding, without ignoring the actual conflict. The urgency right now is on the Israel and Palestine Conflict. But his work can be valid for other conflicted parties too. Hosted on Acast. See acast.com/privacy for more information.

Today, I am talking with Gul Dolen, a pioneering neuroscientist from Berkeley University and a leading expert in social behavior, psychedelics, and brain plasticity. Gül’s groundbreaking research has uncovered how hormones like oxytocin and serotonin interact in the brain to produce feelings of social connection. She has also explored how psychoactive drugs like MDMA can enhance social behaviors across species, including octopuses. Most recently, her work investigates how psychedelics can reopen critical periods of social reward learning, offering new hope for understanding and treating social disorders. We talk about the reopening of the brain’s critical periods and how MDMA therapy can change your mind.Find more information here.https://psychology.berkeley.edu/people/gul-dolen Hosted on Acast. See acast.com/privacy for more information.

This is the third special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests in this episode are the hilarious comedian Dennis Walker, the energetic Co-founder (with Myriam Barthes) and CEO of Journey Clinical Jonathan Sabbagh, Philip Drechsel, my Co-Founder of The New Health Institute, and Tom Feegel, Co-Founder of the ibogaine clinic Beond (with Talia Eisenberg) Joe and I talk about the language of healing and how we communicate this to others, when we need to change all together. As Philip shared his healing story with ibogaine, it became clear what a healing opportunity we could experience here. FOLLOW ON IG:The@mycopreneurofficial @jonathansabbagh @beyond.us @thenewhealthinstitute @thenewhealthclub @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.

Today’s episode is particularly special. I recorded this session in our hotel room studio during the Psychedelic Science Conference in Denver. The duo you’ll hear shortly is truly exceptional in their efforts to destigmatize psychedelics, a movement gaining significant momentum right now. My guests are Professor Rachel Yehuda and Governor Rick Perry. Professor Rachel Yehuda is the Director of the Parsons Research Center for Psychedelic Healing at the Icahn School of Medicine at Mount Sinai in New York City. She plays a pivotal role in pioneering psychedelic research related to veterans and PTSD. Governor Rick Perry is a prominent American politician and the former governor of Texas. He also served as the 14th U.S. Secretary of Energy from 2017 to 2019. Perry has argued that ibogaine could be an incredible treatment for addiction and PTSD in veterans and has dedicated himself to advancing the public understanding and acceptance of psychedelics. In this episode, we discuss the evolving landscape of psychedelics in the United States, exploring why a bipartisan approach could be a powerful solution for rescheduling psychedelics and expanding access to healing therapies nationwide. IG @rachelyehudaphd @secretaryperry https://www.nga.org/governor/rick-perry/ https://labs.icahn.mssm.edu/yehudalab/yehuda-team/ Hosted on Acast. See acast.com/privacy for more information.

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Daniel Goldberg Co-Founder and Partner at Palo Santo & Bridge Investments & Zac Kamenetz, Founder of Shefa: Jewish Psychedelic Support, Joe and me were talking about the interactions of psychedelic community, the new role of Venture Capital in 2025 and what psychedelic systems are built in the current climate to support individuals and the bigger picture. Check out this episode, it's fun and very insightful. Check out: https://www.shefaflow.org/ https://palosanto.vc/ Hosted on Acast. See acast.com/privacy for more information.

This is a special episode I recorded in collaboration with Joe Moore from Psychedelics Today at the largest conference in the field "Psychedelic Science 2025" in Denver last week. It very early in the morning, at 8am, and it was fabulous. Our guests: Tommaso Barba, Neuroscientist from Imperial College London and Dee Dee Goldpaugh, therapist, author and clinical consultant, me and Joe were talking about Sex, Intimacy and Psychedelics! Check out this episode, it's fun and very insightful.IG: @Tommaso.barba @deedeegoldpaugh @psychedelicstoday Hosted on Acast. See acast.com/privacy for more information.

Episode Highlights: Introduction to the Situation in Europe:Overview of Europe's stance on psychedelics and its progress in psychedelic therapies.Historical context: France was the first to prohibit psychotropic substances ahead of the U.S. in the 1960s.Current Research and Stigma Issues:Czech Republic as a pioneer in continued psychedelic research amidst widespread European prohibition.Switzerland's advancements since 2014 in psychedelic therapies for certain conditions.Organizational Efforts and Personal Motivation:Discussion on initiating a European movement to integrate psychedelic therapies.Founder’s background from Strasbourg and motivation for creating the initiative.Challenges in Promoting Psychedelics in the EU:The struggle of integrating a cohesive plan across diverse cultural and political landscapes in Europe.Advocacy through European Citizen Initiative to push legislative changes.Strategic Goals and Legislative Pathway:Campaign to collect 1 million signatures to obligate EU action on psychedelic policies.Goals include establishing common standards for psychedelic care and boosting EU-funded research.Mental Health Crisis and Economic Considerations:Addressing Europe's mental health and economic burdens through psychedelic therapies.The disparity between European initiatives and more advanced legislation in the US and Australia.Public Engagement and Advocacy:Engaging content creators, influencers, and medical professionals in the conversation.Efforts to destigmatize psychedelics by raising public awareness.Impact of Cultural and Political Differences:Addressing the unique cultural and political challenges within different European countries.Adapting strategies to fit local narratives and cultural sensitivities.Looking Ahead:Potential benefits and implementation pathways for psychedelic therapies in Europe.The need for collaboration and knowledge-sharing among EU member states to advance policies and public understanding.Call to Action: Encouragement for listeners to support the European initiative by signing petitions and spreading awareness.Suggestions for engaging in community discussions and using social media platforms to advocate for change.Conclusion: Emphasize the importance of unified efforts to address mental health crises in Europe through innovative therapies.Listeners are encouraged to stay informed and take action to support the movement for psychedelic-assisted therapies.Additional Resources: Follow the New Health Club podcast for further discussions on psychedelic therapies.and check out https://www.psychedelicare.eu/ Hosted on Acast. See acast.com/privacy for more information.

Here is the new podcast episode with Casey Spooner, our first live podcast at Fotografiska in Berlin! Casey, a multifaceted artist renowned for his innovative blend of music, performance, and visual arts shares his personal, emotional story and very non - linear healing story. Spooner was born in Athens, Georgia and attended the University of Georgia and the School of the Art Institute of Chicago. He has contributed to performances with the Doorika collective and joined the experimental Wooster Group ensemble in 2007. He released solo work starting in 2010, including the album "Adult Contemporary." Spooner opened for Scissor Sisters in 2011 and released a single "I Love My Problems" in 2020. Spooner co-founded the musical duo Fischerspooner with Warren Fischer in 1998. The group released several albums and was known for their performance art and immersive enterprises. Spooner primarily wrote songs and performed vocals. In our conversation Casey takes us through his plant medicine journey and his way to search for new healing modalities. @Caseysponner Hosted on Acast. See acast.com/privacy for more information.

Simon Schnapper is an incredible force in the psychedelic space. Investor with the JLS Fund, impresario, seeker, supporter. I finally had him on the show and this episode is about Simeon’s perspective on the "industry" in relation to psychedelics. We talk about -Balancing spiritual/healing aspects with business realities-The rapid evolution of the psychedelic space-His family history with the Peace Corps-Global perspective on psychedelic markets-Experience with iboga in Africa-Discussion of PTSD treatment potential-Examples from Balkans and other conflict zones-Iboga's unique properties for trauma-Simeon's approach to investing in psychedelic companies-Balancing profit motives with ethical considerations-Thoughts on patents and IP in the industry-Challenges of "extractive" interactions-Simeon's experiences trying to give backIdeas for more ethical engagementCheck out his work.https://www.linkedin.com/in/simeonschnapper/www.jls.fund Hosted on Acast. See acast.com/privacy for more information.

In this conversation Marissa Feinberg and me explore the intersection of psychedelics and climate action, discussing how psychedelics can foster a sense of oneness with nature and help alleviate eco-anxiety. We delve into the growing recognition of eco-anxiety in psychology, the shift of climate issues from fringe to mainstream, and the role of youth activism through movements like Fridays for Future. The discussion also touches on the importance of community, the impact of personal choices on climate guilt, and the transformative potential of psychedelics in fostering compassion and empathy towards the environment. We also explore the intersection of climate action and psychedelics, discussing the challenges of climate messaging, the importance of community and personal connections, and innovative solutions to environmental issues. So how can psychedelics facilitate self-discovery and a reconnection to nature, while also emphasizing the need for localized climate initiatives and collective healing. This dialogue highlights the urgency of accelerating consciousness shifts to inspire meaningful climate action. TAKEAWAYS Psychedelics can inspire a profound oneness with all life. Eco-anxiety is one of the fastest growing areas of psychology. A consciousness shift is necessary for meaningful climate action. Psychedelics can help individuals reconnect with nature and their agency. Climate guilt can arise from awareness of personal choices impacting the environment. Community engagement is essential for collective climate action. Experiencing psychedelics can enhance compassion and empathy towards the environment. The climate crisis is increasingly recognized as a mental health issue. Shifting from numbing to caring about the environment is vital for progress. Funding cuts can hinder climate organizations' messaging. Psychedelics can lead to deeper self-awareness and healing. Experiences in nature can foster a sense of peace and connection. IG: @MarissaFeinberg https://www.psyca.org/ https://www.nytimes.com/events/speakers/marissa-feinberg Hosted on Acast. See acast.com/privacy for more information.

Is the west on its own healing journey? Shows like "The White Lotus" and the rise of Ayahuasca in the western world show how much we are in need of tools. But we did not create these tools by ourselves. My guest today, Dr. Sergio Perez Rosal is the perfect partner to talk about the idea of bridging different cultural perspectives, acknowledging both the challenges and teachings from various traditions and how to be aware of reciprocity, if it comes to indigenous cultures. Dr. Sergio Pérez Rosal is a pioneer in integrating traditional medicine with psychedelic treatments. With a background in anesthesia and emergency medicine, he advocates for a holistic approach to mental health. His 'Fundamentals of Health' concept combines psychedelics, lifestyle changes, and mindfulness to enhance well-being. As a faculty member in the University of Ottawa’s Psychedelic and Consciousness Studies program, he leads in psychedelic research and education. Featured in his TEDX talk and outlets like Forbes, Sergio envisions a future where health is cultivated through the transformative power of psychedelics.What you should know: Cultural Crisis: The West faces a crisis not just of mental health but of meaning, driven by materialism and disconnection from spiritual values.Romanticization of Other Cultures: There is a tendency to overly romanticize Eastern and Indigenous cultures as solutions to Western spiritual emptiness, overlooking their complexities and challenges. The use of psychedelics in these cultures Importance of Reciprocity: Engaging with Indigenous practices requires an understanding of reciprocity, respect, and cultural sensitivity, fostering true intercultural exchange.Psychedelic Integration: Successful outcomes from psychedelic experiences depend on proper guidance, intention, and post-experience integration rather than relying solely on the materials themselves.Building Bridges: Initiatives that merge Western and Indigenous perspectives can create a deeper understanding of consciousness and healing, benefiting both communities in navigating the complexities of mental health and spirituality.Check out @search_md on IG Hosted on Acast. See acast.com/privacy for more information.

This conversation with Talia Eisenberg and Tom Feegel from Beond delves into the evolving landscape of Ibogaine as a treatment for addiction and mental health issues. We discuss the increasing mainstream acceptance of Ibogaine, its cultural and spiritual significance, and the unique experiences it offers compared to other psychedelics. And we emphasize the importance of understanding both the scientific and traditional contexts of Ibogaine, as well as the personal journeys individuals undergo during treatment. We discuss the importance of community support in the healing process, the challenges of navigating relationships post-recovery, and the need for a deeper understanding of addiction as a response to underlying pain. Finally, we share the vision for the future of Beyond, emphasizing the need for expanded access to effective healing technologies and the importance of research and policy change. And we discuss a topic on the rise: addiction. Here are the most important takeaways: Ibogaine’s Growing Acceptance – It is becoming more mainstream with significant potential for addiction and PTSD treatment. Deep Healing & Reset – Ibogaine offers a unique, long-lasting journey (up to 48 hours) that resets brain chemistry and supports emotional healing. Cultural & Spiritual Significance – Understanding its roots and integrating both clinical and spiritual aspects is essential. Commitment to Change – True healing requires a willingness to transform, reframe identity, and navigate shifts in relationships. Community & Support – Peer support and shared experiences enhance the healing journey and prevent isolation. Addiction & Trauma Connection – Addiction often stems from emotional pain, trauma, or spiritual disconnection. Expanding Access – Healing technologies should be democratized, integrated into healthcare, and backed by research and data sharing. Find BEOND here. WEBSITE; https://beondibogaine.com/ INSTAGRAM: @beond.us Hosted on Acast. See acast.com/privacy for more information.

This is probably the most personal podcast & video I recorded so far.Together with my Co-Founder of The New Health Institute Philip von Drechsel I sat down and we both opened up about addiction, trauma and the PTSD we were carrying around in very different ways.Which became the reason why we founded The New Health Institute. Our mission is to change perceptions and lives by advancing knowledge and access to psychedelic mental health care.In the last weeks I was thinking a lot about how much I should talk about my actual story and my trauma. But some things made me do this.having a founding partner that came out with his own story about his addiction listing to Tim Ferris talking about his child abuse healing story and listening to Amy Griffin on Oprah’s book club about her story in “The Tell made me feel validated, brave and ready to talk if we share our trauma, it seems no longer so scary. We can heal from that. In community, in telling others who understand my recent MDMA assisted therapy session made me loose my shame and fear, that wasn’t mine anyway, so I could finally TALK the insight that the shame belongs to the abusers, not the person that experienced the abuse we should be able to talk about trauma and addiction in a new and normal way. And how psychedelic assisted therapy can help us to heal from it. Please check out:Website: www.thenewhealthinstitute.org Instagram: @thenewhealthinstitute @thenewhealthclub Hosted on Acast. See acast.com/privacy for more information.

Today I am talking to Patrick de Jongh founder of "When Nature Calls” in Amsterdam: you could say the fanciest smart shop in Amsterdam, hands down. But it is more than a smart shop. The store shows how a stylish and modern place to sell innovative wellness products can look like. No old and dusty space cakes here! Patrick founded “When Nature Calls” 26 years ago, and has been on a mission to disrupt and challenge the wellness industry to offer more to society ever since. The store in Amsterdam carries a great selection of functional mushrooms, truffles and innovative products from the new wellness industry. Microdosing for example has become an integral part of Patrick's wellness routine, helping him to stay more mindful and motivated. In the last 26 years he become an expert in developing a new idea around mushrooms related and psychedelic welllness. Now the store is expanding, tuning into a first version of future wellness center with products and treatments. Patrick and I talk about how create a high end brand in the new psychedelic wellness sectorhow his own experiences in the psychedelic space are connected to his business sense how psychedelic regulations and politics are affecting a psychedelic business, even as a wellness companyhow the future of a possible global new wellness centre can look likeWebsite: https://whennaturecalls.nl/ IG: @whennaturecalls.center PLEASE enjoy 10% off their truffle products: Code THNC x WNC Hosted on Acast. See acast.com/privacy for more information.

Get ready for an exhilarating ride! Today, I’m joined by the incredible Jon Hopkins, a Grammy-winning artist revolutionizing the psychedelic music scene. We dive into his latest album, RITUAL, alongside his collaborator, Dan (aka 7rays). Picture this: our podcast unfolds in an unusual setting — a children's room adorned with an army of plastic soldiers! Jon's mesmerizing soundscapes transcend the ordinary, transporting listeners to new dimensions, whether on or off psychedelics. With a history of collaboration with legends like Brian Eno, Coldplay, and David Holmes, and a milestone album, Music for Psychedelic Therapy, under his belt, Jon crafts powerful soundtracks for mind-bending journeys. we uncover the magic behind his creative genius, the stories that inspire his compositions, and the transformative power of music and reality, all while exploring the allure of RITUAL. @mrjonhopkins (IG) @7rays-devon Hosted on Acast. See acast.com/privacy for more information.

Let’s celebrate. This is episode 100! My guest is Jonathan Sabbagh, Co-Founder of Journey Clinical and I talk about normalising Ketamine therapy for all, plus why PTSD can fire up your career - until you realize it is harmful to you. Since a few years I am following Jonathan and his wife and Co-Founder Myriam Barthe’s great work around the idea to build a strong, decentralized network and offerings for KAP (Ketamine Assisted Psychotherapy) to empower as much therapists as possible to execute the therapy. They did an incredible and successful job to make Ketamine therapy available and build a strong system in collaboration with therapists and doctors. In this episode is talk to Jonathan about: -how PTSD can give you a skyrocketing career, until you realiize your “energy” is trauma in disguise -how we both were very good in PTSD friendly jobs (banking & media) and left them because we realised our own PTSD -how Journey Clinical helps therapists to support their patients with ketamine therapy, (eventually psilocybin) if they are interested in trying and why normal “therapy” needs a strong transformation What Journey Clinical does Journey Clinical is on a mission to transform the growing mental health crisis by accelerating the mainstream adoption of legal, evidence-based Psychedelic-Assisted Psychotherapy as the standard of care for mental health, starting with Ketamine-Assisted Psychotherapy. They have built a leading platform for Psychedelic-Assisted Psychotherapy in the US. They also recently announce a research collaboration agreement with Compass Pathways to inform the development of a scalable delivery and training model for COMP360 psilocybin treatment. Which means, together with Compass, they work on a future delivery model for psilocybin therapy. INFO @journeyclinical @Jonathansabbagh www.https://www.journeyclinical.com/ . Hosted on Acast. See acast.com/privacy for more information.

I have the pleasure of speaking with Elise Loehnen, one of my favourite authors whose storytelling resonates deeply with me. We share a journey of realizing the toll of overwork, anxiety, and the pursuit of wellness as a cure-all, only to discover the transformative power of psychedelics. Elise's expertise in content creation was evident during her tenure as the chief content officer at goop, where she co-hosted The goop Podcast and The goop Lab on Netflix. Her role involved spearheading content strategy, including the successful launch of a magazine with Condé Nast and a book imprint. With a Bachelor's degree from Yale, majoring in English and Fine Arts, and a rich media career, Elise brings a wealth of experience to her work. Now based in Los Angeles with her husband, Rob, and their sons, Max and Sam, Elise continues to inspire through her writing and editing. As the host of Pulling the Thread, a podcast with Cadence13, she engages cultural luminaries on pressing questions for our society in featuring notable figures like Dr. Gabor Maté and Dr. Temple Grandin. Despite co-authoring twelve books, including five New York Times Best Sellers, Elise's latest venture, her first book under her own name, "On Our Best Behavior: The Seven Deadly Sins and the Price Women Pay to Be Good," has captured attention as an instant New York Times bestseller. Our conversation naturally gravitates towards psychedelics, exploring the pivotal role MDMA played in Elise's journey, her transformative experiences with 5 MEO Dot, and the evolving landscape of psychedelic exploration in adulthood.” @eliselohenen https://www.eliseloehnen.com/ https://www.eliseloehnen.com/episodes Hosted on Acast. See acast.com/privacy for more information.

This episode is sponsored by Magi Ancestral Supplements, whose leading team of neuroscientists, ethnophamacologists, and phytochemists, has unlocked the formulation of an ancient Eastern psychoactive elixir that was lost to time. Lets talk about ancient alchemy today! Today I chat with Dr. Shauheen Etminan, the founder of VCENNA an advanced biotech company specializing in natural drug discovery for mental health, seamlessly blends ancient Eastern medicine with modern science. As a scientist, researcher, product developer, and dedicated entrepreneur, Dr. Etminan is committed to creating holistic wellness solutions rooted in the convergence of medicine and …mysticism. Armed with an MSc and Ph.D. in Chemical Engineering, Dr. Etminan's expertise extends beyond the technicals. He is a mystic who has been practicing Sufi whirling meditation for many years, reflecting his deep commitment to holistic well-being.
Renowned as a world expert in phytochemical extraction technology, Dr. Etminan explores the realm of psychedelics with a particular focus on ancient texts. Dr. Etminan and his team have unveiled neurological health properties in beta-carbolines. This groundbreaking discovery has led to the formulation and launch of multiple psychoactive supplements designed to promote longevity, mindfulness, and therapeutic benefits under Magi Ancestral Supplements. Ancestral Magi is co-founded by Dr. Shauheen Etminan and has the legendary Dr. Dennis McKenna on its scientific advisory board. They have combined modern neuroscience with ancient Eastern medicine to formulate 100% natural nootropic supplements that are psychoactive and legal! Magi's products' primary group of compounds are beta-carbolines extracted from the sacred plant, Espand, also known as Syrian rue. Their products promote neuro-longevity, mindfulness, and mental wellbeing. Did you know that Espand has the same psychoactive compounds that exist in the Ayahuasca vine? I'm not relating to DMT, but beta-carbolines. Experience the magic of their supplement, Stard, Magi's meditation supplement, which has been my favorite. It provides 60 to 75 minutes of pure bliss, where the mind stops wandering and can be present in the here and now. (Whether you're new to meditation or a seasoned practitioner, Stard is an ancestral catalyst that will take you further on your journey) Magi’s supplements are fully legal and currently available in the US. Stay tuned, as they will be available in Europe in July. Check their website out at www.ancestral.magi.com. As the valued audience of The New Health Club podcast, you can use the coupon TNHC10 to get a 10% discount. Follow Magi Instagram @ancestralmagi Website: www.ancestralmagi.com Shop here: Magi Homepage: https://ancestralmagi.com/ref/9/?utm_source=podcast&utm_medium=&utm_campaign=THNC.D1.Q22024&utm_id=20240606 Magi Shop Page: https://ancestralmagi.com/shop/ref/9/?utm_source=podcast&utm_medium=TNHC&utm_campaign=THNC.D1.Q22024&utm_id=20240606 Magi Stard Meditation Supplement: https://ancestralmagi.com/product/stard-deep-meditation-supplement/ref/9/?utm_source=podcast&utm_medium=TNHC&utm_campaign=THNC.D1.Q22024&utm_id=20240606 Hosted on Acast. See acast.com/privacy for more information.

Today I am speaking with Madison Margolin, an author, journalist, editor, consultant, educator, and guide to all things Jewish-Psychedelic. She is the also the former Co-Founder of the Double Blind magazine about the new culture of psychedelics. Her book. Exile and Ecstasy Growing Up with Ram Dass and Coming of Age in the Jewish Psychedelic Underground is pretty fascinating.Exile and Ecstasy sets out to explore the psychedelic path that occupies the crossroads between the Ram Dass movement and Judaism. It’s a path of seeking and escape, rebellion and return, medicine and magic. It’s a path that ultimately points toward home. Through the perspective of having grown up among “HinJews” in the Ram Dass community and in the cannabis legalisation movement, journalist Madison Margolin takes the us on a journey inside New York’s Jewish counterculture and the Hasidic underground, reconciling her roots, tackling ancestral Jewish trauma, and finding intersectionality between the Jewish and psychedelic experience. This book is for anyone looking to feel spiritually kindled, to make peace with where they come from, and to reconcile seemingly disparate experiences of spirituality and psychedelics with traditional religion.I think in these times we live in, books like this are really necessary. https://www.madisonmargolin.com/ Hosted on Acast. See acast.com/privacy for more information.

Have you thought about changing your mind, I mean really change it? And have you thought about going on a trip? I mean a psychedelic trip? There will be more and more facilities in the future where you can do this in a safe set and setting, also in a legal setting. My podcast is a space were I introduce these places to you and today I am talking to Ingmar de Gooijer, the Founder of Magnolia in the Netherlands.A place which offers individual psychedelic programs. Magnolia supports patients and clients in gaining access to their inner healing intelligence and activating it. After a thorough screening, each patient and client follows a personalized program that includes the administration of a psychedelic substance. Magnolia offers Ketamine therapy for patients under the medical supervision of psychiatrists, psychologists, and physicians in a mental health treatment environment. As well as experiences with psilocybin-containing truffles facilitated by experienced guides. I believe that these experiences will become way more normal in the future, and also destigmatized. Ingmar de Gooijer and I talk about the new type of customer looking for an experience, about the changes psychedelics created in our own lives and about a new idea around personal health care. @mymagnolia www.mymagnolia.nl/en Hosted on Acast. See acast.com/privacy for more information.

Social scientist Rachelle Sampson & Regenerative economist Bennet Zelner are working on a super interesting study and program. Designed for executive leaders facing an increasingly complex world, the Connected Leadership Program explores the potential of psychedelics to unlock greater creativity and resourcefulness for navigating complexity. The program includes an in-person retreat at Kiyumi Retreats in the Netherlands, as well as virtual group and individual executive coaching sessions before and after the retreat. Enrollment is currently open for two cohorts starting in June 2024 and October 2024. This program was developed in conjunction with the Connected Leadership Study, a novel research project led by Rachelle Sampson, Ph.D. and Bennet Zelner, Ph.D., faculty at the University of Maryland’s Smith School of Business who appeared on my most recent podcast episode. The study examines whether and how perspective shifts from psychedelic experiences affect decision-making in organizations. In the podcast, we talk about the future of leadershipthe future of psychedelic leadershipwhy we love to watch bad leadership on TV, why Don Draper was a traumatized leader and why Ted Lasso and Taylor Swift are modern ego-less leaders for the psychedelic age.how a study about psychedelic leadership and the C-Level looks like and why these experiences could lead us to a whole new idea of leaders.More Info here. https://ww2.kiyumi.org/connected-leadership-for-a-regenerative-future/ https://www.linkedin.com/in/bennet-zelner-7220b261/ https://www.linkedin.com/in/rachelle-sampson-68a3b610/ Hosted on Acast. See acast.com/privacy for more information.

I wrote 40 e-mails to Carl Hart to ask him for a podcast. and I would have written 50.To me he is one of the most fascinating scientist that came on the radar in the context of the psychedelic renaissance a few years ago. Finally two weeks ago, I was able to talk to him at Neue House in New York. Dr. Carl L. Hart, Ziff Professor at Columbia University and former chair of the Department of Psychology. is is one of the world's preeminent experts on the effects of so-called recreational drugs on the human mind and body. Dr. Carl Hart is open about the fact that he uses drugs himself, in a happy balance with the rest of his full and productive life as a researcher and professor, husband, father, and friend. In his book Drug Use for Grown-Ups, Hart draws on decades of research and his own personal experience to argue definitively that the criminalization and demonization of drug use--not drugs themselves--have been a tremendous scourge on America, not least in reinforcing this country's enduring structural racism.Dr. Hart did not always have this view. He came of age in one of Miami's most troubled neighborhoods at a time when many ills were being laid at the door of crack cocaine. His initial work as a researcher was aimed at proving that drug use caused bad outcomes. But one problem kept cropping up: the evidence from his research did not support his hypothesis. From inside the massively well-funded research arm of the American war on drugs, he saw how the facts did not support the ideology. The truth was dismissed and distorted in order to keep fear and outrage stoked, the funds rolling in, and Black and brown bodies behind bars. "Drug Use for Grown-Ups" is controversial, but Carl's way of talking about the war on drugs and how it brought us here where we are in terms of body autonomy, is fascinating. In this podcast we discuss all kinds of things around drugs, but mainly we talk about the autonomy of body and mind. https://psychology.columbia.edu/content/carl-hart https://drcarlhart.com/ https://www.penguinrandomhouse.com/books/534657/drug-use-for-grown-ups-by-dr-carl-l-hart/ IG: @carlhart Hosted on Acast. See acast.com/privacy for more information.

This episode was not very easy to do. It was a difficult conversation. Very open, very vulnerable, but it was a conversation I wanted to have with a the Safe Heart foundation- A Professional support for the survivors of the music festivals on October 7th in Israel. We decided to keep this episode as little political as possible. So we would be able to take about what happened on and after the rave with the people attending the rave, where the got attacked and how their trauma played out in the aftermath of the event. Safe Heart is a mental health organization bringing together a professional network of clinical psychologists, psychiatrists, clinical social workers, psychotherapists and qualified clinical instructors, all of whom have experience working with severe traumatic experiences and in the field of psychedelic harm reduction and integration. I am talking to Dr. Demian Halperin Head of psychiatric support MD, Board-certified psychiatrist and psychotherapist. And to Guy Simon, Board Member, Chairman of the Clinical Advisory Committee M.A, M.S.W, PhD(c), Psychotherapist with expertise in trauma. Clinical Director at Impulse. Specializes in relational psychoanalysis and Buddhist psychology. We talk about how to work around a special traumatising experience of the people being attacked while partying, while being on a psychedelic substance. We talk about how the whole experience of October 7th can influence everyone on a global level and what this could mean for a treating trauma with psychedelics. I am very proud of this conversation, we managed to stay informative, yet being able to voice pain, trauma and the effect the event had on the jewish community. If you know someone who could use help after the events, please get in touch here. https://www.safeheartil.com/en info@safeheartil.com Hosted on Acast. See acast.com/privacy for more information.

My guest today is David Orren CEO and Co Founder of Gaba Labs. David and his team are producing a drink called Sentia, Sentia has been created with the research support of Professor David Nutt, one of the most important psychedelic researchers contributing to the new psychedelic industry and science. (check out his organization DRUG SCIENCE) A drink that gives us everything we want from alcohol, but without the alcohol. With over 40 years experience, David is one of the world’s foremost experts on alcohol and its effects. David co-founded GABA Labs in order to achieve the vision of bringing greater choices to adult social drinkers. Sentia is the first consumer-facing brand to evolve from this breakthrough work. It’s kind of the third way: neither alcohol nor alcohol-free Sentia is a so called GABA Spirit, the world’s first truly functional alcohol-alternative category, a blend of functional botanical ingredients, designed by the science team at GABA Labs to offer that 'two drink sweet spot’. So Sentia enhances your Gaba receptor, no alcohol involved. It is designed to create the togetherness and celebration we are used to experience with alcohol.But what if we would not use alcohol any more to connect? Also Sentia has been created with the research support of Professor DAVID NUTT, one of the most important psychedelic researchers contributing to the new psychedelic industry and science. With over 40 years experience, David is one of the world’s foremost experts on alcohol and its effects. David co-founded GABA Labs in order to achieve the vision of bringing greater choices to adult social drinkers. Sentia is the first consumer-facing brand to evolve from this breakthrough work. Its kind of the third way: neither alcohol nor alcohol-free. David and I talk about why we drink and how drinking is part of our communication system- why new molecules will replace our “old” ways of stimulating our brains and bodies, without being psychedelics why human beings will always look into celebrations and substances to support a collective “party” experienceshow the alcohol industry might changewhy starting a psychedelic journey makes you stop drinking alcoholAnd just for you. Please use code : ANNE15 for 15% off for your Sentia order sentiaspirits.com (Code expires 31st March 2024)Instagram: Sentia Spirits Website:sentiaspirits.com Hosted on Acast. See acast.com/privacy for more information.

Todays opic might seem like a harsh one. PTSD Post traumatic stress syndrome and how it could be healed with MDMA therapy or ibogaine soon. But the world should be informed what this looks like, especially in the current state. Civilians and veterans are suffering. We are exposed to a whole new situation of trauma and war, even just watching what is happening can cause re traumatisation. As heavy as this topic is, I firmly belief the knowledge around healing modalities should be out there. My guests today are real experts on the topic.Amber Capone is the Co-founder and Executive Director of VETS Inc. (Veterans Exploring Treatment Solutions, Inc. Co-founder and Executive Director ) a pioneering organisation providing resources, research, and advocacy for U.S. Special Operations veterans seeking psychedelic assisted therapies abroad. Amber has served as the engine behind the dynamic success of the VETS mission since it’s inception in 2019, raising funds to support hundreds of veterans, spouses, and Gold Star spouses, while also spearheading research and legislative initiatives at both the state and federal levels. A natural born complex problem solver, Amber is committed to fighting as hard for other veteran families as she did for her own following a tumultuous return to civilian life after her husband, Marcus’ 13 year career as a US Navy SEAL. Jonathan M. Lubecky, U.S. Army SGT(R) , is the founder of Lubecky Strategic Direction, Veterans & Governmental Affairs Liason for MAPS, and VP Communications at Apollo Pact. He is a 12-year retiree of the U.S. Armed Forces, serving in both the Marine Corps and the Army. He has been a freelance journalist since 2014. Since 2016 he has been a Strategic Communications & Governmental Affairs Consultant advocating for psychedelic medicine and Veterans. Jonathan returned from a deployment to Iraq in 2006. Shortly after returning, he was diagnosed with posttraumatic stress disorder (PTSD) and a traumatic brain injury. While battling PTSD, enduring multiple forms of treatment, and taking dozens of pills per day to manage symptoms, he attempted to take his life five times. While recovering from that fifth attempt in the hospital, he was instructed to “Google MDMA PTSD”. Beginning exactly 8 years after being released from active duty from Iraq, Jonathan began MDMA-assisted therapy in a MAPS Phase 2 study and completed the protocol in early 2015. As of November 22, 2022 he has been healed of PTSD as long as he had PTSD Jon was appointed the National Veterans Director for the Rand Paul for President campaign. Realizing the potential of psychedelic medicine to heal his fellow veterans and the millions of Americans suffering as he once did, he has been involved in media, politics, and government affairs, with a focus on the Department of Defense, Department of Veterans Affairs, and Media ever since receiving MDMA therapy. https://vetsolutions.org/ https://www.lubeckysd.com/ INSTAGRAM: @marcus_amber_capone @jonathanlubecky Hosted on Acast. See acast.com/privacy for more information.

Today I talk to Sandra Statz, Founder and CEO of A.P Chem. Sandra is Beauty executive. Chronic pain navigator. Mother. Sandra is a business leader and brand creator with more than 15 years of experience in the beauty industry working with brands including La Mer, Guerlain and Clinique. She’s also a ketamine advocate – an educator and confidant for those exploring psychedelic treatment. She is also a member of the board for The Ketamine Fund and KetaMD. A.P Chem's mission is inspired by her journey following a life-changing medical diagnosis that led to her discovery of psychedelic treatment. The goal here is to break down taboos, destigmatize health conditions and illuminate options. A.P Chem creates a safe space to explore and share varying points of views while respecting everyone’s path to wellness is unique and deeply personal. We talk about a psychedelic brand, how Sandra’s skin care can raise awareness for psychedelics and how working with adaptogenes in your skin care is amazing for you skin, we address Sandra's healing journey with Ketamine and how the future of psychedelic brand building can look like. https://www.apchembeauty.com/ INSTAGRAM : apchembeauty Hosted on Acast. See acast.com/privacy for more information.

Just imagine, you are running a company. And you would like to offer a better mental health care for your employees, maybe psychedelic therapy? Sounds crazy? It is not. It is it already working. In the coming years, companies will have to change to supoort their employees differently. I finally have Sherry Rais on the show, a fascinating founder and CEO of Enthea. A company that provides access to safe and affordable psychedelic therapy for everyone who can benefit. Established in 2022, Enthea is a mental health company dedicated to providing access to safe and affordable psychedelic-assisted therapy, beginning with ketamine therapy. As a public benefit corporation, we are prioritizing the removal of health equity obstacles that impede people from receiving impactful mental healthcare services. Sherry Rais, MSc, has helped dozens of startups, non-profit organizations, academic/research institutions, and small businesses raise funds, operate according to their mission and values, and implement processes that enhance their overall efficiency. Sherry believes in living and working in alignment with purpose and is currently focused on expanding access to psychedelic-assisted therapy to alleviate human suffering. Before this, Sherry consulted for over 10 years with the United Nations and World Bank, implementing cash transfer programs at the national level in over 35 countries. Sherry holds a Master’s Degree in Public Policy and Management from the London School of Economics and a Bachelor’s Degree in Psychology and International Development from McGill University. She also completed the Certificate in Psychedelic Therapies and Research from CIIS in 2021. In addition to being Enthea's CEO, she is the Executive Director of the Boston Psychedelic Research Group and the Grants Manager for CIIS. We talk about, why poverty is trauma related, why offering healing as a founder and a company owner be important and why new tools and psychedelic “incentives” are here, how this works compliance and data wise, why we won’t be able to live without new healing modalities and an idea of new health, on the job and at home. WEBSITE: https://www.enthea.com/ SHERRY RAIS: https://www.linkedin.com/in/sherryrais/ Hosted on Acast. See acast.com/privacy for more information.

We are finally back! Today I talk to Suzanne Khan and Alice Policand, founders of Bien Health, Suzanne is a biochemist engineer who worked for L’Oreal, Alice is a luxury marketing specialist who worked for LVMH. But then they met and decided to build a great looking micro dosing brand from Paris. To me their brand was one of the first psychedelic brands that look really chic, I could see it carrying around in my handbag.It feels "normal" to carry truffles round that way. Will this be our future? Will we experience a post anxiety revolution?We talk about a growing community of micro dosing fans, why people are actually looking into it, how a psychedelic brand can and should look like these days and we talk about Alice and Suzanne's personal journeys, and how a scientist and a fashion and luxury expert got the world of psychedelics. And yes, we met in Paris and had the best eclair ever.Website https://bien.health/Instagram: https://www.instagram.com/bien.health/FOLLOW US ON INSTAGRAM:@the.newhealthclub@philippianneAND SUBSCRIBE TO OUR NEWSLETTERhttps://thenewhealthclub.substack.com/ Hosted on Acast. See acast.com/privacy for more information.

Here is Volume 2 of our Psychedelic Morning Show! Our second episode is really insightful, watch out for new ideas, new approaches in psychedelics. Our guests this time are a great mixture which roles psychedelics can play in out future lives. Meet Tommasso Barba, PhD candidate at Center for Psychedelic Research, Imperial College London talking about sex, psychedelics and connection. The topic will become extremely important in our disconnected times. Bob Wold, Founder of Cluster Buster, an advocacy group for people suffering from Cluster headaches had touching stories to tell, how to treat extreme migraine with psychedelics. Take a look at his conference, it is worth it! And finally Allison Hoots, Attorney at Hoots Law Practice and advocate; President of Sacred Plant Alliance is on the show. One of most interesting psychedelic lawyers in the US and expert in how to open and create an Ayahuasca Church. Hosted on Acast. See acast.com/privacy for more information.

In today's episode I present you our first Psychedelic Morning Show, Vol.1. A great live podcast collaboration I did with Joe Moore, from Psychedelics Today at the Psychedelic Science conference by MAPS in Denver, this June. To me, it was an incredible joint venture of two podcast. And a community service at a very early time of the day! (We kicked off 7.30 am, like good morning show does!) And we tried to keep it… fun! Trying to talk about drugs, weather and coffee, like you do in a morning show. Our first episode is wild. We had Julie Holland American psychopharmacologist, psychiatrist, and author plus Daniel Goldberg, Co- Founder of the Palo Santo Fund on the show, both famous for their highly entertaining conversations. Plus Melissa Lavasani, Founder and Chief Executive Officer at Psychedelic Medicine Coalition, Founder and President of Psychedelic Medicine PAC and Tracy Tee, founder of Moms on Mushrooms: watch out for their March of Mums in Washington next year. And the great Hadas Alterman, Director of Government Affairs | American Psychedelic Practitioners Association. Please enjoy Volume One! Volume two is one the way in 2 weeks!https://www.palosanto.vc/https://drholland.com/https://www.linkedin.com/in/melissalavasani/https://www.momsonmushrooms.com/https://www.linkedin.com/in/hadasalterman/ Hosted on Acast. See acast.com/privacy for more information.

This episode is in German, and there are reasons why. Since my guest today is Finn Age Hänsel, founder of Sanity Group, I thought it was time to give an update in german, what actually has happened and maybe will be happing in a near decriminalised cannabis and psychedelic future. Finn and I talk about how cannabis could treat ADHD in grown ups and I am very grateful that Finn is sharing his own story here. We talk about why are Germans terrified of substances and compounds and why we should stop using the word DRUGS all together. We also talk about why every Cannabis and Psychedelic company has the duty to help destigmatizing cannabis and psychedelics Finn himself is a German consultant and entrepreneur. He is the founder of the Berliner Berg brewery and Sanity Group, the former CEO of the moving company Movinga. He is also a member of the federal board of the Bundesverband Deutscher Start-ups e.V.Finn was born in Flensburg, he founded his first company at the age of 17 with an online store for secondhand sportswear He joined the Junge Union and after graduating from high school in 2001, received a scholarship from the Konrad Adenauer Foundation, which he used to study business administration at the Technical University Bergakademie Freiberg. In 2010, Hänsel founded the online retailer The Iconic. He also took on the position of Marketing Director at the investment company Rocket Internet in Australia the following year. After returning to germany, Finn worked for high end accelerators and consulting companies. Since 2002 Finn had campaigned for the decriminalization of cannabis as a member of Junge Union. After cannabis and cannabinoids were approved as medicinal products in Germany, Hänsel entered the distribution of medical cannabis. In 2018, he and Fabian Friede founded Sanity Group, which supplies pharmacies and drugstores with cannabidiol products. Two years later, the company joined forces with Aphria and Cannacare to launch the industry association Pro CBD, which they use to raise awareness about cannabis. And yes, Snoop Dog is one of his investors! Hosted on Acast. See acast.com/privacy for more information.

This is one of the nerdiest episode at the TNHC so far, but also one that’s really necessary right now. In this episode I am talking about AI and Psychedelics with the amazing AI expert Nicole Büttner, Founder & CEO of Merantix Momentum. Merantix believes that to unlock the profound potentials of AI, a collaborative approach is needed. My second guest is the great Sergio Pérez Rosal, MD, part of the MIND Fundation and the CEO and Medical Director at OVID Clinics in Berlin, an established clinic in Berlin that works with Ketamine. What is the connection between psychedelics and AI? Is there one? It seems pretty much so. “Sam Altman, chief executive of OpenAI, is chairman of a start-up (Journey Colab) that aims to tap into the promise that psychedelic drugs have shown in clinical trials — and make them broadly available for people who suffer from mental health and drug-use disorders. The man bringing artificial intelligence to the masses through the viral chatbot ChatGPT wants to revolutionise mental health care and addiction treatment with psychedelic drugs”. writes The Washington Post.There are more things to address which I did with my great panel happening at Soho House Berlin a few weeks ago. So the three of us talk about if we need psychedelics to understand AI. And if AI will be a really productive drug developer ? And there is more: Can AI give you a spiritual experience? And will we need additional dimensions and tools to understand out future all together ? God, there are so many questions. https://www.merantix.com/https://ovid-clinics.com/ Hosted on Acast. See acast.com/privacy for more information.

Lauren Taus has become quite a name in the psychedelic world. She is based in Los Angeles and is a licensed psychotherapist practicing Ketamine-assisted Psychotherapy (KAP) in Los Angeles, California. She integrates modern science and ancient wisdom to support personal transformation and much needed systemic change. She started “Inbodied Life” as a private psychotherapy practice, and it blossomed into a group practice that is also a platform for education through in-person, experiential trainings and retreats. Lauren sits also on the advisory board of Journey Clinical, an amazing psychedelic company based in NYC. To me, Lauren is one of the most interesting and also important people in the new psychedelic space. Her social media language is really speaking to me, since she has a great way to really get into the important questions around psychedelics: how does change actually look like? On a daily basis ? Why do we all need TO, which means “time out” and how psychedelics can support us with that. We address Laurens way from anorexia to healing and her way through the 12 steps program, we talk about her about her acid trip with her dad, a doctor, who now works with her And how it works, if your family is starting to look into psychedelics too. And of course we talk about how a psychedelic journey can bring fun to our lives. Something I feel we should also talk about more often and with Lauren this is possible. https://www.inbodiedlife.com/https://www.journeyclinical.com/ Hosted on Acast. See acast.com/privacy for more information.

We finally can reveal what we were working on last month, besides the first TNHC retreat.Together with the Canadian company Dimensions, we will Co-Create psychedelic retreats in Europe, starting this autumn in the Netherlands with magic truffle experiences. Dimensions offers safe and legal plant medicine-assisted experiences for personal growth and well-being.In December last year I was a guest at the Dimensions retreat and this changed my perspective on the topic of psychedelics, cannabis, retreats and the importance of somatic work. I Do think that cannabis can offer psychedelic insights too, helping you to heal on a really deep level. Let me quickly introduce Dimensions. This is a place to reconnect, an opportunity to heal and a path to lasting transformation. Whatever your intention. Dimensions invites you to unlock your potential for well-being while experiencing warm hospitality in luxurious natural settings.So of course I wanted to chat with the CEO of Dimensions, Christopher Dawson and the COO Andrew Galloway about their personal plant medicine journey, the idea of Cannabis retreats and cannabis as a ceremony, the importance of science informed and trauma informed retreats and of course we will outline how the New Health Club and Dimensions and the Co-Creation for a strong network of retreats in Europe can look like.https://dimensionsretreats.com/ Hosted on Acast. See acast.com/privacy for more information.

My guest today is Cindy Gallop or Lucinda Lee Gallop. And she is quite something! I wanted to have Cindy on the show, because she engaged on a psychedelic journey (with 62) not because of mental health reasons. She embarked on a truffle journey, just out of very simple curiosity. And lust for life. And resetting perspectives. To me Cindy’s case also has an element for future ideas around longevity: what happens, if we keep our brain young? And how will this affect our body? Cindy says about herself to be “boringly drug resistant” but after her experience , things, aka her life changed. Cindy says. “ What it did just reinforce for me was a sense of history and the broadness of humanity. And the importance in the future, looking into the void, of finding light and connections.” Cindy Gallop I would say, is a real de-stigmatisation pro, a genius if it comes to tell it like things are. And then make them market ready. You guessed it, Cindy was an incredible advertiser, a female Don Draper, and we had many conversations over dinner about the rebranding or re-naming of psychedelics. Cindy studied English literature at Oxford University, receiving an MA in English language and literature. She was an English advertising consultant, founder and former chair of the US branch of advertising firm Bartle Bogle Hegarty, worked on accounts like Coca Cola, Ray Ban and Polaroid, In 2003, Gallop won the Advertising Woman of the Year award from Advertising Women of New York She is also the the founder of the companies IfWeRanTheWorld and MakeLoveNotPorn. According to the TED blog, Gallop's TEDTalk "Make Love Not Porn" was one of the "most talked about presentations'' at the 2009 TED conference. She founded her own brand and business innovation consultancy, Cindy Gallop LLC, in 2006. https://makelovenotporn.tv/ https://cindygallop.com/ Hosted on Acast. See acast.com/privacy for more information.

This is our second life recording at Soho House Berlin. This time, we are talking about a topic that is just developing as we speak. Psychedelic leadership.What does it actually mean? Does it mean C Level people will engage in psychedelic experiences to look for better leadership practices and transformation? Does it mean at one point companies can offer psychedelic therapy to their employees? Does it mean we will look into psychedelics for inspiration if it comes to business or creative ideas? Or does it mean we are looking for a new leadership style all together, with the support of psychedelic experiences?Also, could we resolve epigenetic questions? Long standing political conflicts ? Many things to address and I was lucky to have a pretty good panel to reflect on all these questions In this episode I am joined by Jörg Reinboldt, MD at APX Axel Springer Porsche, entrepreneur, investorDr. Gesa Miczaika, General Partner at Auxxo Female Catalyst Fund, PhD Dmitrij Achelrod, Helping leaders thrive at Evolute Institute. |And Achim Feige,.Co -Founder of Vertical Development, Transformation Architect I Human Potential Coach. https://apx.vc/https://www.auxxo.de/https://evolute-institute.com/ Hosted on Acast. See acast.com/privacy for more information.

Dr. Molly Maloof, physician and entrepreneur, kind of the female pendant to Andrew Huberman, is finally on the show today! Molly Maloof is one of the first people I read about, in terms of the new psychedelic space. Molly is one of the people in the psychedelic space, who marries science, medicine and psychedelics. Working on future topics in psychedelics, he has a pretty impressive track record of engagements in the new health space. She is the Founder & CEO, Adamo Bioscience, working on biological, psychological, psychedelic, and technological solutions to become the foremost scientific company perpetuating the power of love. She was a lecturer at Stanford University, taught the course “Live Better Longer: Enhancing Healthspan for Longer Lifespan” within the Wellness Department of the School of Medicine. (She received the highest student ratings in the department) She is the founder of DrMolly.co, a modern health and wellness media brand that inspires, educates, and motivates people to make the rightlifestyle choices so they can actualize their potential. She is the medical advisor: for Neurohacker, Drugs over Dinner, Osmind ect. Now, Molly has just released her new book “The Spark Factor”.“A breakthrough program for women to revive their lost energy and vitality, developed by a leading biohacker and physician. In her book, Molly talks about the spark we are all looking for on a daily basis. With cutting-edge biohacking insights, strategies for personalized nutrition, hormonal health and stress management, The Spark Factor is the book women have been waiting for to help them reclaim their vitality and achieve lasting health.” Molly and I talk aboutsupplement overkill and pill fatiguethe redefinition of stress and healththe possibility to address sexual trauma with the support of psychedelicssexual psychedelic therapy for the masses, the limitations of classic couples therapy and why we share so many phantasies around love drugs and love potions.More Info: https://drmolly.co/ Hosted on Acast. See acast.com/privacy for more information.

This is the last episode for 2022 and what a year it was. But before 2023 starts, we have a great episode for you, which gives you a taste of what’s to come at TNHC in 2023: live podcasts and events with an audience. I find this such an energetic experience to have an audience in the room and also provide room again for live Q & A. My guest was Rock Feilding-Mellen. He is from the family of Beckley organisations in the UK. And one of these companies is Beckley Retreats, which he co-founded with his mother, Amanda Feilding, who is also the founder and CEO of the Beckley Foundation, a great friend and inspiration to me. The Beckely foundation spear-headed much of the most groundbreaking scientific research upon which the new psychedelic renaissance is being built right now. But being the son of the “Queen of the Psychedelic Renaissance” likes Forbes calls Amanda, wasn’t always easy for Rock. In this episode Rock talks about his route, via business and politics, to the realisation of how transformational and healing psychedelic assisted therapy can be. And how Europe will play a big part in the current booming psychedelic renaissance. https://www.beckleyfoundation.org/ Hosted on Acast. See acast.com/privacy for more information.

My guest today is Patrick Cox and I have to say, he is a very special guest, because I bought his shoes to be cool. Patrick’s shoes made you belong to the so called cool Britannia in the 90ties: The band Oasis wore them, glamorous DJs and rockstars, cool Londoners, the cool nightlife world wore them. More than that. The whole fashion world liked Patrick’s fashion taste. Patrick was a design super star, his nickname, Janet Jackson gave it to him, was "Party Pat". And Party Pat had everything. Celebrity friends like Elton John lots of money, charm, party stamina, talent, humour, until these things turned out to cover up his old trauma, the one that he experienced at age 4. Patrick never thought about it any more. But a few years ago, Patrick lost everything, his company and his ability to ignore the old trauma with his certified tools: travelling, partying and ignoring. So he tried everything, to save his mental health, but nothing worked. He even told his friends about a possible suicide. Before it was too late, he found toad venom, aka 5 MeoDMT. Toad Venom is found in the poison of Bufo alvarius, a toad native to the Sonoran desert in Mexico. After a few experiences, Patrick said, he didn’t hate himself any more. he found out, there was nothing wrong with him. The only question was, who would he be now? Patrick and I talk about how an intervention form Elton Johns feels like, how alcohol lost it’s so called cool, why heavy partying and depression are siblings, how generation X never leaned anything about healing. And how trauma, you have experienced so long ago, will catch up with you, even if you have everything you think we should have. Hosted on Acast. See acast.com/privacy for more information.

“The workplace & mental health 3.0”Tobias Silberzahn is a Partner in McKinsey’s Berlin office where he is a member of the Healthcare Practice and the Innovation Practice. McKinsey, called “The Form”, is one of the most famous management consulting groups and supposed to know it all. They charge corporations top dollar to help them run with state-of-the-art efficiency. McKinsey gets called in when things are good or bad to help bosses make difficult decisions. Over the last 13 years with McKinsey, Tobias has served mainly digital health startups, established healthcare companies and ministries of health. He lead McKinsey's global Health Tech Network, a community of >1500 digital health companies. His focus area is healthcare innovation and health-tech business building where he supports clients on R&D, commercialisation and scaling questions, he also hosts the McKinsey MedTech R&D Roundtable, the Pharma Technical Development Forum. Within McKinsey, he co-leads the health & wellbeing programs for employees in Germany and Austria, focused on sleep, nutrition, stress management and fitness. So Tobias needs to look into new mental health tools if it comes to employees, but at one point he might look as McKinsey into psychedelic pharma companies. Tobias and I talk about the great resignation, the idea of health that Generation Z, Millennials and generation X has developed and the future of a corporate mental health can look like. And, as you can imagine, I try to engage with Tobias in a conversation about how psychedelics will enter a future work space, since all the current corporate companies are really challenged and need to change from within. Lets see, how. Hosted on Acast. See acast.com/privacy for more information.

I can finally welcome Dr. Gabor Maté on the show! One of the most empathic, unapologetic and science driven people in the mental health space. I love that combination! And yes, we are also talking about psychedelics and trauma, but what I really like about Gabor is that he sounds like a contemporary, cool philosopher, helping to explain the exciting and disruptive times we live in. Dr. Gabor Maté is a Hungarian-Canadian physician and author. He has a background in family practice and a special interest in childhood development and trauma and in their potential lifelong impacts on physical and mental health, including on autoimmune disease, cancer, attention deficit hyperactivity disorder (ADHD), addictions, and a wide range of other conditions. Maté's approach to addiction focuses on the trauma his patients have suffered and he looks to address this in their recovery. We address, how most psychiatrists today are trained in a narrow fashion, Gabor’s ayahuasca ceremony and how he learned about his closed heart, the deepest pain and the deepest love and that our healing in the present and within ourselves. I can highly recommend really all of his books.In the Realm of hungry ghostsWhen the Body Says No; The Cost of Hidden Stress;Scattered Minds: The Origins and Healing of Attention Deficit Disorder; and (with Dr. Gordon Neufeld)Hold on to Your Kids: Why Parents Need to Matter More Than PeersThe Myth of Normal: Trauma, Illness & Healing in a Toxic Culture. https://drgabormate.com/ Hosted on Acast. See acast.com/privacy for more information.

Jamie Wheal is the author of Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind, and the Pulitzer-nominated global bestseller Stealing Fire: How Silicon Valley, Navy SEALs, and Maverick Scientists Are Revolutionizing the Way We Live and Work. He is the founder of the Flow Genome Project, an international organization dedicated to the research and training of human performance. His work and ideas have been covered in The New York Times, Financial Times, Wired, Entrepreneur, Harvard Business Review, Forbes, Inc., and TED. He has spoken at Stanford University, MIT, the Harvard Club, Imperial College, Singularity University, the U.S. Naval War College and Special Operations Command, Sandhurst Royal Military Academy, the Bohemian Club, and the United Nations. Jamie and I talk about the collapse of meaning in the the last decades and how meaning 3.0 could actually look like. What a modern “Alchemist Cookbook” is and why ethical cult building could be interesting. Plus: Jamie explains how flow looks like and what is has to do with the six neurotransmitters. And of course we talk about the current state of psychedelics and how to avoid “bliss junkies and epiphany whores,” as he says. But still, will the future be your and my brain on psychedelics?https://www.flowgenomeproject.com/https://www.stevenkotler.com/book-pages/stealing-fire Please note also: The New Health Club is now a proud supporter of International Therapeutic Psilocybin Rescheduling Initiative, a global coalition working to reschedule psilocybin under the 1971 Convention on Psychotropic Substances. With partner organizations such as MAPS, the Beckley Foundation and Drug Science. ITPRI is working bring down barriers to advancing psychedelic medicine. Please check them out at reschedulepsilocybin.org and consider donating to support their work. Hosted on Acast. See acast.com/privacy for more information.

Robert Bent works with the VC fund Vine Ventures and is co-founder and CEO at Othership, a global community to improve mental health in an accessible way. Othership combines beautiful social spaces that deliver peak experiences and a mobile app that teaches breathwork. Prior to Othership, Robbert was Ecosystem Growth lead at the Ethereum Foundation. He graduated from the Richard Ivey School of Business.Roberts story is a modern one. By late 2013, after being super successful, Robert hit rock bottom. He felt burnt out, low, tired from his career in finance, was struggling with a substance abuse problem. He escaped to Israel, tried a ten day Vipassana retreat, finally went to Peru to try Ayahuasca.From here, Robert's life changed: he engaged in breath work practices, joined Vine Ventures and co-founded “Othership". Roberts vision, as he says,” is to create space that encourages openness to the awe, belonging, and interconnectivity that animates the human experience for a more joy-filled life and living.” He is building a platform that includes physical spaces, a mobile app, a concert tour and a global community. Robert and I talk about the Othership Community.how to use ice bathing and sauna to keep reflecting on your psychedelic experience, why people stop consuming alcohol once they engaged in psychedelics and how a future life with an integrated idea of psychedelics looks like. https://www.othership.us/apphttps://www.othership.us/physicalhttps://vine.vc/ Hosted on Acast. See acast.com/privacy for more information.

Julie Holland is an American psychopharmacologist, psychiatrist, and author. She is an really important voice in the new psychedelic world, we are just creating. She is the author of five books, including Moody Bitches, Good Chemistry, Weekends at Bellevue: Nine Years on the Night Shift at the Psych ER, a memoir documenting her experience as the weekend head of the psychiatric emergency room at Bellevue Hospital in New York City. She is an advocate for the appropriate use of consciousness expanding substances as part of mental health treatment, she is a medical monitor for MAPS studies, which involve, in part, developing psychedelics into prescription medication.Holland sits on a few advisory board, for example Palo Santo and to me, she is one of the most inspiring people in the space. What I like about Julie? She is non judgemental, she always sees the bigger picture in the psychedelic renaissance, and she is a lot fun to talk to. Please enjoy! http://drholland.com/ Hosted on Acast. See acast.com/privacy for more information.

And just like that, there will be a whole new generation of politicians working on integrating psychedelic assisted therapy in the healthcare system and into new laws. How will the BTM (Betäubungsmittelgesetz in Germany) look like? Will we see a decentralization of mental health care? Why is pretty much everyone microdosing, although it is still really illegal? I am thrilled to talk to Mario Brandenburg from the FDP party today about the coming years, psychedelics and yes, Germany.Mario Brandenburg, born in Rhineland-Pfalz, is a spokesman for research, technology and innovation for the Free Democrats FDP (https://www.fdp.de/) Brandenburg is in the German Bundestag, chairman of the Education and Research Working Group, deputy member of the Digital Agenda Committee and memberof the german Bundestag, Last year, he was one of the first politicians in Germany, who started to look into the possible rescheduling of psilocybin and made a request, how the old government under Angela Merkel could be encouraged to spend more money on clinical trials in terms of psychedelics. Now, since the election, Brandenburg is part of the new government and might be one of the german politicians engaging in making psychedelic assisted therapy available in Germany in the coming years. In May 2021, Brandenburg and some FDP colleagues submitted a so-called "Kleine Anfrage zu Medizinische Forschung mit Psilocybin und anderen psychedelischen Wirkstoffen in Deutschland”, in which he presented a list of questions to the federal government at the time, on the basis of which the government had to provide information about the current assessment of psilocybin as a therapeutic agent. We talk about legalization of cannabis in Germany and the decriminalization movement in the US, the decentralized mental health models and what would happen if you don't have to wait months to see a psychiatrist or therapist, the War on Drugs, why FDP leader Christian Lindner is talking about ending the criminalization of users and 'draining the black market’, why the Germans are afraid of microdosing and Silicon Valley why after the pandemic and Covid, we might need a speedy decriminalisation of new psychedelic tools and therapy that will help us to really cope with the massive wave of mental health problems. https://www.mariobrandenburg.de/https://www.fdp.de/https://www.fdpbt.de/anfrage/kleine-anfrage-medizinische-forschung-psilocybin-und-anderen-psychedelischen-wirkstoffen Hosted on Acast. See acast.com/privacy for more information.

Journey Clinical, Jonathan Sabbagh and Myriam Barthes, is my guest today. VCs named their company one of the top 15 startups in the psychedelic field. Journey Clinical is a turnkey telehealth platform that enables licensed psychotherapists to include legal, evidence-based Psychedelic Assisted Psychotherapies (PAP) in their practice, starting with Ketamine-Assisted Psychotherapy (KAP). Their novel decentralized clinic model provides member psychotherapists with unprecedented access to a KAP-trained medical team, as well as a robust care management platform designed to deliver personalized treatment plans for enhanced clinical outcomes. Myriam describes the new clinical system as a triangle.In the first corner is the patient, in the second the journey clinical doctor, who is able to describe and administer the ketamine, in the third corner is the Journey Clinical member psychotherapist, vetted and often independent, who works with the patient after the treatment. Jonathan describes the company as a “one stop shop where all the required treatments get offered to you”. Which means, as a patient, you would not have to run around to physicians, psychiatrists or therapists,who would eventually contradict each other in their diagnosis or where at least one party would not be open to Ketamine Assisted psychotherapy. Journey Clinical is your new psychedelic in house doctor. Both founders have a background in finance and both have experienced how their lives have transformed with psychedelics. Jonathan, working in hedge funds, suffered from a heavy burn out and undiagnosed PTSD and addiction condition, he looked into an ayahuasca and MDMA experiences. Myriam is a firm believer in plant medicine, she had her own psychedelic healing story.We talk about, how therapists join the network, can access educational videos , then join peer consultation groups and then can start referring patients to the ketamine therapy, how Ketamine can support tapering off antidepressants that patients will still need to take, how repressed feelings and underlying topics of patients made their way to the top during COVID, which amplified peoples crisis and depression even more, how with a few Ketamine Assisted Psychotherapy sessions things start to bubble up, how the modern psychedelic clinic can look like very soon.https://www.businessinsider.com/list-top-psychedelics-startups-according-to-vcs-investors-2021https://www.journeyclinical.com/ Hosted on Acast. See acast.com/privacy for more information.

My guest on The New Health Club Show today is Sa'ad Shah, managing partner of the Noetic Fund. Saad basically grew up all over the world, went to the JFK School in Berlin, worked in real estate banking, corporate credit, and derivative sales & trading.–and he holds a BA in Economics and Political Science from Columbia University.The Noetic Fund is a powerful investment group in the new psychedelic field, a group of venture funds launched by Grey House Partners GP Inc. to invest in emerging and early-stage wellness, therapeutic and pharmaceutical companies around the globe, The fund has $170 million in assets under management and is one of the venture-capital firms that's deployed the most funding into the psychedelic industry. The firm has invested $56 million in psychedelics since early 2020, when Shah started the fund. (Companies like Beckley Psytech,Gilgamesch, Bexson, ASRI, CaaM/Tech, Eleusis)Sa'ad and I talk about his interest in theology and mysticism as an investor and eventually taking ayahuasca in Brazil: his own classic hero’s-journey type of story. We address how his own interest and fascination with psychedelics became his new path in life, and what he is looking for, when he invests in a company How to nurture the “the scientific advancement of mental, emotional, psychological and physical health by investing in alternative therapies, modalities, and sciences that are committed to optimising our human experience” which is the Noetic vision and no small plan.(https://noeticfund.com/) Hosted on Acast. See acast.com/privacy for more information.

Hans van Wechem & Jeanine Souren from FieldToday I am talking about couples and (magic) truffles, and yes, I mean psychedelic assisted couples therapy. So why could this type of therapy be groundbreaking for the coming years? Why could it be a version of therapy 2.0? And if so, what would it look like? Who would you and your partner be, if you met without the trauma you might carry with you? Today, we got two experts, who are executing an interesting version of truffle assisted couples therapy. I talk to the therapist Jeanien Souren and psychiatrist Hans van Wechem, both are in charge of couples therapy at Field Trip in Amsterdam. With an extensive professional career in mental health, Jeanine Souren holds degrees in psychology, psychotherapy, clinical sexology and couples & family therapy. She is accredited and licensed in the Netherlands and has worked as a lead clinician in several mental health settings. She is passionate about the therapeutic potential of psychedelics in combination with psychotherapy. Jeanine believes that by tapping into the deep psyche through psychedelics, suppressed patterns, emotions and beliefs can be made conscious again, allowing for healthy change.Hans van Wechem has almost 30 years of experience in psychiatry and started his career as a registered couples and family therapist before specializing in (group) psychotherapy of patients with early childhood trauma and attachment disorders. After a life-changing psychedelic experience, he recognized the potential of psychedelics in therapy. He now contributes to projects such as MAPS in their efforts to investigate MDMA for the treatment of PTSD and has a wide network in the psychedelic community. His main interest lies in contributing to a future in which the use of psychedelics will become widely accepted, both as an evidence-based treatment and as a powerful catalyst for personal and spiritual growth.https://www.fieldtriphealth.nl/ Hosted on Acast. See acast.com/privacy for more information.

My guest today is Onur Yildirim, Director of Field Trip Health Amsterdam, a place that offers legal, safe and vetted experiences and possibilities to rediscover life through psychedelics. Field Trip Health stands for scientifically supported, legal psychedelic experiences that liberate and inspire you, and works with a step-by-step, professional approach to the use of psychedelics. This includes preparatory sessions and integrative therapy sessions. In Amsterdam Field Trip is working with truffles, in The US and Canada with ketamine. Onur, who leads a team of experienced therapists and psychiatrist at FT; was originally trained in clinical psychology and worked as a psychologist during the first years of his career. Later, Onur earned his PhD in neuroscience from Radboud University and worked in the R&D and MA of established pharmaceutical companies such as Johnson & Johnson and Novartis, where he championed the research of psychedelic molecules as potential antidepressants. After his time in the pharmaceutical industry, he began his entrepreneurial career which eventually led him to Field Trip. Onur and I talk about what happens if you make the decision to engage in a psychedelic journey at FT, who are the people that are interested in this and why the times of Covid are encouraging people to look into psychedelic support systems, if possible. And full disclosure, I have done a guided Truffle experience at Field Trip in Amsterdam and it brought me many new insights. I decided to engage in a truffle experience twice year - a tool to support my own life's and founder's journey. Hosted on Acast. See acast.com/privacy for more information.

My guests today are the architects Ester Bruzkus and Peter Greenberg and you might wonder: what will we talk about in a podcast like this one, if not about psychoactive compounds and psychedelics? And where does architecture comes in?Founded in 2002 in Berlin, Ester Bruzkus Architekten is an internationally established architecture and interior design practice with global ties, but based in Berlin. They are well known for extensive experience with design at many scales: from the design of tables and furniture to exquisite residences and workspaces to international theatres, restaurants and hotels. Ester was named as one of Architectural Digest’s “Top 200 Influencers in the Design World,” Growing up in Berlin, she studied architecture at Berlin’s Technical University and later at the School of Architecture in Belleville, Paris. Before founding her own Berlin office in 2002. Peter received his Master of Architecture from Harvard’s Graduate School of Design and graduated cum laude with Distinction in Architecture from Yale University where he also studied philosophy and the history of art. He is a licensed architect in the United States in Massachusetts and New York and is a certified Interior Designer. Since Peter has become Partner, the firm has won several international design competitions, has won many design awards, and has completed several significant projects, including the restaurants Remi and Villa Kellermann Tim Raue, and projects for Relaxound, Volkswagen’s Autostadt, and the PSD Bank. As you can see, here are two pros to talk about trauma, but this time not in brains, but in buildings and houses. The question is though, can buildings be as traumatized from severe historic incidents, as much as brains? And could this have an effect on people living in these buildings? Of course, the follow up question I am asking myself would be: could the trauma and the aura of a building be transformed, if these buildings might host psychedelic treatments and can we help buildings to heal? And redefine them? ? But let’s ask Ester and Peter, the experts on room karma and real building therapists. (https://esterbruzkus.com/) Hosted on Acast. See acast.com/privacy for more information.

My guest is Patrick Moher, CEO at Microdose Psychedelic Insights and creator of the Wonderland Psychedelic Conference in Miami. Patrick is an entrepreneur working in Psychedelics and Cannabis. He is a passionate and unapologetic environmentalist, founded Ethical Image, co-founded a couple of companies. I have met Patrick many times last year, mostly on Air Table, where he hosted the Micro Dose conference virtually. With Microdose online, one was able to see, what was happening in the incredible new field and the big names of the psychedelic renaissance all made their appearance.But now, Wonderland is near, the first big IRL conference in Miami, where most people in the psychedelic world will meet the first time. (Who knows, maybe Wonderland might become the Art Basel Miami for Psychedelics? )The event will certainly be an important meeting of science, capital and entertainment, meaning names like Mike Tyson and Lamar Odom speaking about their personal healing with the support of psychedelic therapy. A new development in the recent entertainment world, that I think is becoming very interesting, helping to destigmatize the psychedelic topic. Patrick and Wonderland are providing the first IRL experience for the psychedelic world in years. Hosted on Acast. See acast.com/privacy for more information.

My guests today are Daniel Goldberg and Tim Schlidt, founders of the Palo Santo fund. The two them an their really impressive team got a big plan for the coming years: investing across the new psychedelic ecosystem and funding a new paradigm in well being.Palo Santo’s diversified investment fund is helping to increase the supply of clinically effective and accessible mental health and addiction treatment solutions needed in today’s world. Daniel Goldberg began seeing mental health as part of a spectrum and not something that needs to be so pathologized.As a founder of Palo Santo and Bridge Investments, Daniel has been actively investing with and supporting inspired entrepreneurs for 20 years. Years ago he saw the transformational potential of psychedelic medicines and has developed a deep network of relationships across the psychedelic research and business communities. His passion for the space is purpose‐driven and science informed. He is thrilled to be a part of Palo Santo’s mission of supporting promising treatments while ensuring widespread access to safe, legal, and effective solutions. Tim Schlidt brings extensive knowledge investing across life sciences and healthcare services, and has held a lifelong passion for understanding and improving treatments for CNS disorders. He believes psychedelics are poised to shift the paradigm in mental health treatment and his primary mission in co-founding Palo Santo is to invest in companies and solutions that allow for broad access to those most in need of mental health care. Prior to co-founding Palo Santo, Tim covered the life sciences and health care services sectors as a private equity investor at Madison Dearborn Partners and an investment banker at J.P. Morgan and Greenhill. We talk about Daniels and Tims personal psychedelic experience they had BEFORE the founding of Palo Santo, the shift and the incredible change they saw coming, when a new generation of scientists engaged in psychedelics, about the psychedelic pharma model and what compound is Daniels and Tims favorite and we chat about what will possibly be happening and what I will see, if I would dare to take 5 MEO DMT: but that will happen on the next episode. https://www.palosanto.vc Hosted on Acast. See acast.com/privacy for more information.

Dave Rabin is an MD, PhD, a neuroscientist, board-certified psychiatrist, health tech entrepreneur & inventor who has been studying the impact of chronic stress in humans for nearly 15 years, particularly non-invasive therapies for treatment-resistant illnesses like PTSD. He is the co-founder & chief innovation officer at Apollo Neuroscience and the co-founder & executive director of The Board of Medicine. In addition to his clinical psychiatry practice, Dr. Rabin is currently conducting research on the epigenetic regulation of trauma responses and recovery to elucidate the mechanism of psychedelic-assisted psychotherapy and the neurobiology of belief. He is a practitioner of ketamine assisted psychotherapy (KAP) and is trained in MDMA assisted psychotherapy. With Molly Maloof, Dr. Dave Rabin is co-hosting the psychedelic news hour on clubhouse.(https://www.psychedelicnewshour.com/) We Talk about listeners on Club House that call in high and how to give them a little integration therapy on air . We talk about why epigenetic trauma is such specific thing, hardly explored, but now a really big topic in the psychedelic context and we talk benefits of Ketamine therapy done at home and of course we talk about Dr Rabins company Apollo. Apollo Neuroscience was born from research at the University of Pittsburgh. David Rabin and Greg Siegle PhD worked together at the Program in Cognitive Affective Neuroscience to develop and scientifically prove out the Apollo technology and discovered that certain combinations of low frequency inaudible sound waves (vibration that you can feel, but can’t hear) can safely and reliably change how we feel through our sense of touch, and that we can measure those physiological changes in near real time. Think of Apollo as a smart bracelet that you can wear around your wrist or ankle and works to give you stress-reducing buzzes in times of need. It syncs to the brand’s app, so you can control its touch therapy functions from your phone.I used Apollo often during the pandemic last year and I fell asleep much easier with it, so I can highly recommend it. Apollo calms your nervous system down in very gentle, but effective way. And since you are a part of amazing the The New Health Club Community, you get a 10% discount on the order of the Apollo. Just head over to www.apolloneuro.com and put in the promo code “newhealth 10” Apollo Partner One Sheet Dr. David Rabin's website Apollo Apollo Research Hosted on Acast. See acast.com/privacy for more information.

What if Palestinians and Israelis would do an ayahuasca ceremony together? Would there ne more empathy and mutual understanding after the ceremonies? Scientist Leor Roseman and Peace Activist Antwan Saca really wanted to see what happened then. And so they arranged it, and created a study for The Imperial College in London. They recently launched the study “Relational Processes in Ayahuasca Groups of Palestinians and Israelis. Leor Roseman is a postdoc at the Centre for Psychedelic Research, Imperial College London, where he received his Ph.D. and MRes, under the supervision of Dr. Robin Carhart-Harris and Prof. David Nutt. His research is focused on the neural and psychological correlates of the psychedelic experience, and the therapeutic application of psilocybin for depression. Currently, Leor is investigating the psychosocial potential of psychedelics. Antwan Saca was born in Jerusalem to a Christian family from the city of Bethlehem. He has spent his adult life working towards the dream of peace and justice in the Holy Land. He spent five years at the Holy Land Trust serving also as director of programs, where he experienced community-healing approaches that strengthened his interest in non-violent compassionate activism. Since then, he’s focused on community dynamics and the many forms of personal/collective experienced and inherited trauma that influence conflict resolution in the Holy Land. He believes that healing the pain of the past is a prerequisite for healthy relations between nations and—ultimately—peace. Antwan serves as an associate at Leaders Quest. https://www.frontiersin.org/articles/10.3389/fphar.2021.607529/full https://www.imperial.ac.uk/people/leor.roseman13http://www.leadersquest.org Hosted on Acast. See acast.com/privacy for more information.

Diana Kinnert is a German politician, political consultant, and publisher. In 2015 she became the youngest chief of staff in the history of the Bundestag when she ran the parliamentary office of Peter Hintze. She is a frequent media commentator on public policy in Germany, and is affiliated with a number of think tanks and advisory committees of the Christian Democratic Union of Germany.Kinnert has the right amount of forward thinking and meeting people where they are at. She is also a firm believer that mental health becomes one of the most important things in our society. And, that loneliness can be looked upon as an illness. (In some countries, this is an accepted fact.) I highly recommend Dianas book “Die neue Einsamkeit: Und wie wir sie als Gesellschaft überwinden können” or “The new lonley”. Diana and I talk about this “new lonely” and how it affects not only older people, but a whole new generation of people under 30. There is a certain way of living very casually, not committed to things and people, that leaves a lot of us sad and disconnected. Something that is sometimes hard to figure out or even realise. Especially since this generation is perfectly connected in the digital world. More than anyone else. This explains to me, why we get lots of requests at The New Health Club from young people in their 20 or 30 about micro dosing, and most people tell us they would like to feel, to reconnect, but often can’t say with what and how. The “new lonely”and the rise of psychedelics and psychedelic therapy, is strongly connected. And this is our big topic here. Hosted on Acast. See acast.com/privacy for more information.

When I read about the “Veteran Navy SEAL Advocates for Psychedelic Assisted Therapy” called Marcus Capone, I was wondering, what was this all about? A Navy Seal and psychedelics? I kept reading and quickly Amber Capone, Marcus’ wife, was introduced in the articles, Amber wanted to save her husband from PTSD and, yes, suicide. And make it possible for war veterans to get in touch with psychedelic-assisted therapy by founding the organization Vet Solutions. Amber’s and Marcus’ mission today is to end the veteran suicide epidemic by providing resources, research, and advocacy for U.S. military veterans seeking psychedelic-assisted therapies. Vet Solutions helps veterans and their spouses to access treatment with psychedelic therapies including iboga/ibogaine, ketamine, psilocybin, MDMA, 5-MeO-DMT, and ayahuasca. So far in the US. But their model can work on a global level. The story of Marcus and Amber is a pretty strong one. When Marcus was medically retired after 13 years and multiple combat deployments as a U.S. Navy SEAL, Marcus and Amber thought that life would return to normal. Instead, their struggle had just begun. Marcus was experiencing an escalating myriad of challenges, including depression, isolation, cognitive impairment, excessive alcohol use, headaches, insomnia, and impulsivity. Marcus was diagnosed with post-traumatic stress disorder (PTSD), but, instinctively, Amber felt there was more to be discovered. After learning about the effects of blast waves, concussive, and subconcussive brain injuries, everything started to become clear. Marcus’ military career as an explosives expert, combined with his prior years of contact sports, had left him with the invisible wounds of traumatic brain injury (TBI), a condition that has significant overlap with PTSD and is often not properly diagnosed. So here they are, on the podcast, talking about their journey. https://vetsolutions.org/ Hosted on Acast. See acast.com/privacy for more information.

Meet the Plant Medicine Law Group , the first law firm to emerge in the space with the express purpose of serving the psychedelic and cannabis industries. Partners Adriana Kertzer, Serena Wu, and Hadas Alterman are entering their 8th month with a full roster corporate and nonprofit of clients in both industries. They are here today with the first attorney they added, Allison Hoots, who specializes in religious exemptions for psychedelic use, to reflect on their growth, what they’ve learned, and what they hope to accomplish moving forward. I am a really big fan of the Plant Medicine Law Group, since we started to be present in the psychedelic ecosystem at a similar time, and I love the way they look at psychedelics and the renaissance we are just experiencing. Also they contribute to one of the most important parts in the new psychedelic world: the legal framework.So how do you work in an industry that is working with mostly illegal substances?https://www.plantmedicinelaw.com/ Hosted on Acast. See acast.com/privacy for more information.

Heard of the potential of psychedelics for new ideas on leadership and supporting your creativity as an entrepreneur or executive? Meet my guest and expert on this today! It is Jonathan de Potter, the founder of Behold Retreats a special legal, vetted and safe retreat for leaders, executives and entrepreneurs. And btw, a portion of Beholds revenues is going to Fireside Project - the free psychedelic harm reduction hotline. Jonathan talks to me about the psychedelic CEO, how integration of the psychedelic experience is on of the most important topics after the psychedelic experience itself, how new ideas for a company can come out of an experience all together. But also how much the, often stressed and high pressured personal life of a CEO is connected to all of this and that there is no end of evolution for your consciousness, even if you try so hard to achieve it. So if you you are an entrepreneur , CEO or in a leadership position and you know that the top down fear based hierarchy in companies is in the process of being replaced by a more servant leadership. And that we need new ideas, new structures and new insights for our world, not only in business. https://www.behold-retreats.com/https://firesideproject.org/ Hosted on Acast. See acast.com/privacy for more information.

Yes, it’s the famous Hamilton Morris who is my guest today. Hamilton is an American journalist, documentarian, and scientific researcher. He is the creator and director of the television series “Hamilton's Pharmacopeia”, in which he investigates the chemistry, history, and cultural impact of various psychoactive drugs. Now Hamilton is on the third season of his show, which was released on January 4, 2021.The show runs on Vice TV and YT. Hamilton started to engage early into very personalised and you could say customised research of drugs and substances. He always had an interesting aura around him on camera, a mixture of a daring guinea pig and scientist. The episodes of his show had names, that made it clear . how un judgmental and curious Hamilton was approaching psychedelic substance as his topic. At this point in his life as a psychedelic expert, Hamilton is moving towards psychedelic research, inspired by the great american bio chemist Alexander Shulgin. (https://melmagazine.com/en-us/story/the-magic-chemicals-of-psychedelic-wizard-sasha-shulgin) So for the future, Morris has mainly the tweaking of molecules in mind, and that in the context of a university. Hamilton and I talk about why we are developing a new idea of drugs and psychedelics as we speak, the meaning of molecules and the freedom of researching new molecules, the advantages to approach psychedelics in a completely non-judgmental and undogmatic fashion, and of course we address Hamilton's favorite topic: the Sonoran Desert toad, or Bufo alvarius and the potent psychedelic compound called 5-MeO-DMT.https://www.vicetv.com/en_us/show/hamiltons-pharmacopeiahttps://www.patreon.com/HamiltonMorris Hosted on Acast. See acast.com/privacy for more information.

The episode today will be in german, because my guest today has a good, informative way to talk about the new psychedelics, in german. Since we want to offer and communicate as much information as possible about the new psychedelics for everyone, once in a while we do a show in german. Dr. med. Andrea Jungaberle, based in Berlin, is a perfect guest for this. She is a co-founder and board member of the MIND Foundation. She also serves as OVID Health Systems’ Medical Director and MIND’s Director of Collaboration and Media. She is a clinical specialist in anaesthesia and emergency medicine and is currently training in cognitive behavioural psychotherapy. Andrea’s research interests revolve around the therapeutic application of altered states of consciousness, integration and the essential questions of death and dying. She has facilitated workshops on psychedelic integration with Dr. Henrik Jungaberle since 2015 and is a key contributor to the MIND Foundation’s BEYOND EXPERIENCE program. She is a certified Kundalini Yoga teacher, has participated in several accredited trainings in psychedelic therapy, and is part of the EPIsoDe study team, preparing to treat patients at Charité hospital in Germany’s first modern clinical trial involving psilocybin. Her interests in altered states of consciousness range from psychedelics to breathwork to yoga. In her latest audiobook “Yoga, Tee, LSD,” Andrea shines a light on the many ways humans modulate their consciousness, both intentionally and unintentionally. https://mind-foundation.org/ https://episode-study.de/hgf/ Hosted on Acast. See acast.com/privacy for more information.

Ronan Levy, Co-Founder and Executive Chairman of Field Trip Health and I are talking about Field Trip’s mission to "bring the world to life through psychedelics and psychedelic-enhanced psychotherapy". Especially the opening of Ketamine Clinics, in the meantime in seven locations from Toronto to Amerstedam, has made Field Trip Health last year to one the most important forces in the field and last year the company even went public. Ronan, a lawyer by training, is also a partner at Grassfed Ventures, a venture capital and advisory firm focused on the cannabis and biotech industries and is Chief Strategy Officer and Member of the Board of Directors for Trait Biosciences Inc., a leading biotech company in the hemp and cannabis industries.It was fun to have Ronan on the show again and catch up, also because the world of psychedelics is changing every day. This time, next to Ketamine, we talk about if Ketamine Clinic should look like Soho House, if there is something like an agnostic molecule, we talk Demi Levato's video “Dancing with the devil'', where she shows herself overdosing and addressing her addiction. We talk about the exact meaning of “California Sober”, an approach to recovery that includes drinking alcohol and smoking cannabis in moderation and we discuss if biotech or the recreational side of psychedelics will win the race. So enjoy the show with Ronan and the birds singing in the background, while we are talking.https://www.fieldtriphealth.com/ Hosted on Acast. See acast.com/privacy for more information.

What if some people undergoing psychedelic assisted therapy rather have a picture of Manchester United or Britney Spears on the wall, instead of a buddha and yoga poses? Is this a question of class, just a different idea of spirituality and power objects? This is my favourite topic in the episode with Ben Sessa today. Dr. Ben Sessa is consultant psychiatrist, psychedelic therapist and chief medical officer at Awakn Life Sciences , UK’s first on-the-high-street provider of psychedelic-assisted psychotherapy. Awakn is researching, developing and delivering evidence-based psychedelic medicine to treat addiction and other mental health conditions, and is aiming to open 15 to 20 clinics across the UK and EU in the next 24 months. Patients will be able to self-refer or be referred by their GP (including NHS). Ben focuses on MDMA-assisted therapies, since the substance is further along in the research and legal processes then psilocybin.Though in the meantime, Ben and his team work also with Ketamine as a therapy tool. The need for psychedelic assisted therapy seems higher then ever. Ben tells me, 30 to 40 % of the British population is drinking in a harmful bracket now in the last 12 month of the pandemic. We talk about rather different ways of using psychedelics like ketamine for addiction, MDMA for obesity or psilocybin for anorexia, something Ben, as a fan of creative psychopharmacology, is interested in. We also address what happens, if depression and anti-depressants can become part your identity and how you might be able to get rid of your own old stories about yourself with the support of psychedelic assisted therapy. http://www.drsessa.com/https://awaknlifesciences.com/ Hosted on Acast. See acast.com/privacy for more information.

My guest today is Zac Kamenetz. Zac is a rabbi, community leader, and aspiring psychedelic chaplain based in Berkeley, CA. He holds an MA in Biblical literature and languages from UC Berkeley and the Graduate Theological Union and received rabbinic ordination in 2012. He is also the founder of the Shefa Foundation, for Psychedelic therapy grounded in Jewish spirituality. He was part of a psilocybin study that dosed clergy of various traditions with psilocybin, the psychoactive compound found in psilocybin mushrooms. This conversation is not only exploring new territory like judaism and psychedelics. Zac and I talk the future of psychedelic therapy, in Zac case that could be jewish psychedelic teraphy, with a “jewish set and setting” as Zac describes it. We talk epigenetic trauma and experinces, the new openeness towards religions and psychedelics and why there might be the new health clubs shuls one day. Zac and I talk about how non-jewish people, like me, should start talking to other non- jewish people about the Holocaust, and how psychedelic insight can contribute to this: the recognition and the embracing of pain, guilt and responsibility. I did not expect the conversation and the podcast with Zac would turn into a psychedelic integration session. For me. But the german and jewish history is something that has been on my mind since forever. And now it is time to bring it back as a result of a psychedelic experiences. https://www.shefaflow.org/ https://2021.jewishpsychedelicsummit.org/ Hosted on Acast. See acast.com/privacy for more information.

Today, my guest is Lars Christian Wilde, the President, Chief Business Officer and Co‑founder of Compass Pathways. Compass is a “mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.” as they describe themselves. Compass was one of the first companies engaging in a bigger vision of the substance psilocybin. But back to Lars. He is a special guest to me, since I like his open mind. I remember talking to Lars in one of our first podcasts about vaccine against depression in the future. I also remember how openly Lars talked about his treatment-resistant depression and anxiety disorder and the effects it had on him and the people in his life. He told me about his treatment with psilocybin, that helped him tremendously to begin a new life with a different mental health set. I am always a fan of people, especially entrepreneurs in the psychedelic field, that share their psychedelic experiences and are personally affected by the power of psychedelic substances. In 2020 lot of things have happened at Compass Pathways. In September 2020 the company became a public company, listing their stock on Nasdaq and raising $146.6 million. Compass became one of the most exciting company in the field. Lars and I catch up, what is happening in the Compass World right now. How does a psychedelic public company feels and works different? How does the Compass and Sheppard Pratt collaboration look like, since Compass is opening a Centre of Excellence in collaboration with The Sheppard Pratt Institute for Advanced Diagnostics and Therapeutics in Baltimore, Maryland, to do more research. Their psychiatry department exists since the 1800s. We talk about how Compass works with the Charité hospital in Berlin and how to do conduct a study in times of Covid at all, we discuss COMP360, a psilocybin therapy trial for treatment-resistant depression designed by Compass for future treatments of depression (https://compasspathways.com/) Hosted on Acast. See acast.com/privacy for more information.

I am happy to have Jeremy Weate, board member of Universal Ibogaine, as my guest on the show. He spent 15 years working as a consultant on natural resource governance, providing advice to governments, companies and civil society organisations in over 20 countries. Jeremy also has a decade-long interest in the medicalization of ibogaine in a holistic treatment setting. He visited Gabon in 2016 and was initiated into Bwiti.In 2018, Jeremy helped set up Tabula Rasa Retreat in Portugal, now one of the leading ibogaine treatment facilities in the world. He has organized ibogaine conferences in Vienna, Porto and London. He has a PhD in European philosophy from the University of Warwick, UK.Jeremy and I talk about the face and rules of modern addiction, the coming importance of Ibogaine and why you can’t keep a good molecule down, which is a british, understated way to say: Ibogaine will become a mayor player in the new word of psychedelics treatments. He is now a board member of "Universal Ibogaine" (https://www.ibogaineinc.com/)a Vancouver based company which aims to build a global network of holistic ibogaine-assisted addiction treatment clinics, operating under the brand Clear Sky Recovery, utilizing a proprietary Ibogaine assisted psychotherapy treatment protocol. The treatment protocol has successfully disrupted opioid addiction for over 3,500 people and delivers up to 95% successful detox. Hosted on Acast. See acast.com/privacy for more information.

I talk to, Charley Wininger. Great guy, experienced psychedelic pro. He is a licensed Psychoanalyst and Mental Health Counselor for individuals and couples. Charley is an author and an expert on Psychedelic Drugs, the 71-year-old is a also a relationship counsellor who calls MDMA the “relationship super glue” and just published the book called. “Listening to ecstasy” When reading about Charleys book, I was wondering: is our connection on a neural level the most important one? Charley must know. In is book he talks about his “MDMA” journey with his wife Shelley, since the two of them, you could say, became relationship scientist with the support of ecstasy. Since the ideas of marriage and relationships have changed big time and we seem to need new tools to understand each others minds and hearts. Charley and I talk about the rediscovery of MDMA in the context of the psychedelic renaissance. And how MDMA could supports couples therapy in the future and what that would mean for love. Enjoy Charley explaining a new possible “relationship glue” called MDMA. https://www.charleywininger.com/ Hosted on Acast. See acast.com/privacy for more information.

Today’s show is all about meeting a legend called Stanislav Grof. Why “legend”? Simply, Stan was around when the first wave of psychedelic research started, but more than that, he was a thriving force in bringing psychedelics into psychiatry and helping to create a scientific base to explore psychedelics as a tool. Today, Stanislav is one of the most important sources for the new mental health industry and new psychedelic therapies. I talked to both Stan and his wife Brigitte, collaborators and partners of several years, and also because Stan had a stroke a few years ago, he feels more comfortable with Brigitte by his side. Honestly, I could not believe that this conversation was happening, the possibility to talk to someone from the first wave of psychedelics. Stan is a psychiatrist with over sixty years of experience in research of non-ordinary states of consciousness and one of the founders and chief theoreticians of transpersonal psychology. He was born in Prague in 1931 where he also received his scientific training: an MD degree from the Charles University School of Medicine and a PhD from the Czechoslovakian Academy of Sciences. He was also granted honorary PhD degrees from the University of Vermont in Burlington and the Institute of Transpersonal Psychology in Palo Alto, CA, and the World Buddhist University in Bangkok, Thailand. Dr Grof’s early research in the clinical uses of psychedelic substances was conducted at the Psychiatric Research Institute in Prague, where he was principal investigator of a program that systematically explored the heuristic and therapeutic potential of LSD and other psychedelic substances. Essentially, Grof was one of the first doctors using LSD in psychiatry! In 1969, Dr. Grof became Assistant Professor of Psychiatry at Johns Hopkins University, one of the most important universities now researching psychedelics now. In 1973, he was invited as Scholar-in-Residence to the Esalen Institute in Big Sur, California, where he developed, with his late wife Christina Grof, Holotropic Breathwork, an innovative form of experiential psychotherapy that is now being used worldwide. Esalen is the famous institute in California, where all the great masters of consciousness were teaching (Alan Watts was one of them). Dr. Grof is the founder of the International Transpersonal Association (ITA) and for several decades served as its president. Currently, Dr. Grof is Professor of Psychology at the California Institute of Integral Studies (CIIS) in the Department of Philosophy, Cosmology, and Consciousness in San Francisco, CA. In May 2020 Stan and Brigitte Grof launched their new training in working with holotropic states of consciousness, the Grof® Legacy Training. More Stanislav and Brigitte Grof resources:Stan Grof’s websiteBrigitte Grof’s websiteThe Way Of The Psychonaut (film)The Way Of The Psychonaut (book) Hosted on Acast. See acast.com/privacy for more information.

Today my guest is Brian Muraresku and his book has a similar game changing effect as Michael Pollan’s “How to change your mind”.… except that Brian makes us rethink psychedelics and religion. So just what will the pope have to say? Brian Muraresku graduated from Brown University with a degree in Latin, Greek and Sanskrit and he has been practicing law internationally for fifteen years. In 2016, Muraresku became the founding executive director of Doctors for Cannabis Regulation. In arbitration with the NFL in 2018, Muraresku represented the first professional athlete in the United States to seek a therapeutic use exemption for cannabis. So, what brings the man on a podcast about psychedelics? Brian and I met in an unusual place—yet a very one common for our times—in a Zoom Meeting.This is where I learned about Brian's recently released amazing book, “The Immortality Key: The Secret History of the Religion with No Name”. The Immortality Key is incredible, a journey into the psychedelic origins of the world's great spiritual practices and what those might mean for how we view ourselves and the world around us. Brian researched for 12 years, was able to get in the archives of the Vatican and check if there are any psychedelic hints (pssst …there are!). He travelled Europe to find out how ancient rituals were supported by psychedelic experiences. So did the Ancient Greeks use psychedelics to find God? And did the first Christians inherit the same, secret tradition? Brian's book and theories changed my whole idea coming from a Catholic culture, and growing up as a Catholic girl. So what if our cultures and religions were always based on psychedelic rituals? Just imagine…(https://www.brianmuraresku.com/) Hosted on Acast. See acast.com/privacy for more information.

Today we are checking in with a scientist again, and a really important one for our German-speaking audience. Meet Prof. Dr. Gerhard Gründer, a Professor of Psychiatry and head of the Molecular Neuroimaging Department at the Central Institute of Mental Health, Mannheim. He is the Principal Investigator of the German Psilocybin Depression Trial conducted by ZI Mannheim and Charité Berlin. He is also the Principal Investigator at the aforementioned Psilocybin Depression Study in cooperation with the MIND European Foundation for Psychedelic Research. Just a little note: this episode today will be in German, and we will talk about the first major psilocybin study, which is supported by the German government. There is tons of information about psychedelics already out there in English, but not so much in German. German-speakers, please enjoy our interview! Professor Gründer and I discuss the lack of innovation in psychiatry when it comes to medication, the old school and new schools of depression research, ketamine therapy as a temporary solution, and why depression and mental health will soon be looked at and researched in a new way. Hosted on Acast. See acast.com/privacy for more information.

Meet Paul Stamets, my new favourite Mr. Mushroom. Paul is an American mycologist and entrepreneur. He is an author and advocate of the “medicinal” fungi. Stamets runs “Fungi Perfecti” (https://fungi.com/) a family-owned, environmentally friendly company specializing in using mushrooms to improve the health of the planet and its people. Fungi perfecti has become synonymous with cutting-edge mycological research and innovative mycological solutions. Stamets has been talking about these “Mycologiclal solutions” for years and since the movie “Fantatsic Funghi” (https://fantasticfungi.com/watch/) that everyone should watch, one could call Stamets the most passionate advocate of mushrooms. And yes, also Magic Mushrooms, the ones that changed Pauls life long time ago.He often talk about his experience with Magic Mushrooms and he is pretty well known for his mushrooms micro dosing protocoll. But Paul is not a big fan of using magic mushrooms in any other way then thoughtful and purposeful. And FYI,he loathes the word “shrooms”! Paul is an incredible mind, a perfect guest with millions of stories and one of them is, that Stamets once was the german name Steinmetz from Bavaria and we ended our conversation with me promising Paul to look for his ancestors in Bavaria. So, hey, let’s hear the mushrooms theories it from Paul! Hosted on Acast. See acast.com/privacy for more information.

David Bronner is an incredible American corporate executive and activist. As the top executive at Dr. Bronner's Magic Soaps, David has positioned himself as the “Chief Cosmic Officer” and is known for his activism around a range of issues, especially fair trade, sustainable agriculture, animal rights, and importantly to us, drug policy reform.Full disclosure: David's company Dr. Bronner’s have a special personal meaning to me and to The New Health Club, since the company generously sponsored the podcast for most of 2020 and will continue to do so in the new year. I met David in February this year for the first time in Germany for our first podcast together and none of us knew at that time that we would experience such an exciting year in psychedelics as the one that we’ve had. Dr. Bronner’s as a company has supported the most important decriminalization movements in the US this year such as DC Measure 81–Decriminalize Nature DC, which passed with 76% of the vote and supports the enforcement of laws against natural plant medicines. You might also remember that the chairwoman of Decrim DC Melissa Lavasani was on our show before the US election! Dr. Bronner’s also supported the Oregon Model, Measure 109 which passed with 56% of the vote and legalises regulated access to psilocybin therapy administered by trained state-licensed facilitators in a therapeutic setting. The model already made a big impact on the worth of stocks from both new psychedelic companies and startups.Dr. Bronner’s also supported Decrim Chicago and the spokesperson Daniel Carcillo, an incredible ex-NHL player, who treated his depression with psilocybin. Of course, we also had Daniel on our show too, a very emotional episode indeed and please check it out if you have not done so already.I am thrilled to have David on the show as our last guest for 2020. We talk the exciting year in psychedelics, why the US (and Europe) are so ready for new mental health drugs, we discuss David's German heritage (the Bronner family is originally from Heilbronn), the next level in the upcoming psychedelic world and we are even joined by David’s dog during our talk. Hosted on Acast. See acast.com/privacy for more information.

I talked to Rachel Yehuda, a professor of psychiatry and neuroscience, the Vice Chair for Veterans Affairs in the Psychiatry Department, and the Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine. She also leads the PTSD clinical research program at the James J. Peters VA Medical Center. In 2020 she became director of the Center for Psychedelic Psychotherapy and Trauma Research at Mount Sinai.Rachel is an important woman, and will be even more important in the years to come. She is researching the generational effect of the holocaust trauma. The neuroscientist and I discuss how the Holocaust, famine, and other catastrophic experiences can affect our DNA. And how MDMA therapy might be able to change that.I could not wait to talk to Rachel! She is a specialist in researching epigenetic trauma in the context of Holocaust survivors and she is a pioneer in understanding how the effects of stress and trauma can transmit biologically to the next generation. She has studied the children of Holocaust survivors and of pregnant women who survived the 9/11 attacks. How is it possible that children or grandchildren of traumatised parents struggle with anxiety and depression but not the parents themselves? And where do psychedelics fit into this picture? Rachel will also start a research program to treat these trauma-related depression with MDMA, all in collaboration with MAPS. What happens if one undertakes a psychedelic journey, and experiences their traumatic past during their trip? What does that mean for our future ability to look at the world in general? How can we do the work on post-traumatic growth? What new stories can come from exploring this psychodynamic narrative? And what tools do we need to re-story our past? Using psychedelics and MDMA can be really powerful tools in understanding conflict, shame and guilt on a deeper personal level. Hosted on Acast. See acast.com/privacy for more information.

My guest today is Finn Age Hänsel, Co -Founder of the Sanity Group, ([https://sanitygroup.com/]) which also owns the CDB Brand VAAY. ([https://vaay.com/]) I am big fan of their night CBD Spray called “Mind, Cosy, Back,Doze” It’s my ritual before I go to bed. But back to Finn’s tech career, so far already very impressive. He founded 5 companies. He is an Entrepreneur and CEO for 7 years with a strong passion and and knowledge for product, brand, technology and consumer goods. And he started to speak out for a cannabis decriminalisation at the age of 17, in the conservative party CDU- even more impressive. But now Finn is fully engaging in the idea of Cannabis as a tool, to make life better and healthier, his company Sanity Group is developing innovative cannabinoid-based pharmaceuticals and wellbeing products, which should be widely accessible. I talk to Finn, why and how Cannabis can be a mental health support system, why the winner of this US election are new mental heath drugs. We talk about his early days as a cannabis supporter in a political system and why life as an entrepreneur is so much better and more fun, if you have real mission. Like Finn. Hosted on Acast. See acast.com/privacy for more information.

Today I have Elias Dakwar MD on the New Health Club podcast. He is an associate professor of clinical psychiatry at Columbia University Vagelos College of Physicians and Surgeons. He has conducted laboratory and clinical investigations of the use of Ketamine infusions and mindfulness training to treat addictions. Ketamine is a medication mainly used for starting and maintaining anesthesia where it induces a trance-like state while providing pain relief, sedation, and memory loss. As we speak, Ketamine is being researched and used as an antidepressant and as a tool to support the outcome of psychotherapy. Scientists from Yale call it a “game changer” for psychiatry and mental health, the company Field Trip from Canada has successfully opened legal Ketamine clinics.I talk to Elias how Ketamine works, why it triggers reactions in your cortex that enable brain connections to regrow. We also talk about the possibility of a chemical mindfulness and how Ketamine can be a future tool for mental health treatments. Hosted on Acast. See acast.com/privacy for more information.

The world is suffering from a big metal health crisis and new mental health drugs can be the answer to this crisis. My guest on the show is working on these new drugs: JR Rahn. He is the founder & Co-CEO of Mind Med, a global company that discovers, develops and deploys psychedelic inspired medicines and experiential therapies through FDA clinical trials. JR and I talk about the current status of mental health in the US, and the world, which seems to have never been near as bad as now. “Eleven per cent of Americans seriously considered suicide in June,” Rahn observed—a doubling since last year. “We’re not O.K.” says JR and this has been the case for a while, which turned JR into a passionate founder to help research LSD and MDMA in a new way and turn them into modern mind medicine. We also address JRs personal history with trauma, we discuss the Ritalin and the Xanax generation and why they are often the ones ending up taking anti depressants later in life. I always enjoy talking to JR, I love how passionate he is in bringing the psychedelic industry and renaissance forward, an I love how thinks I sound like a german spy from homeland. https://www.mindmed.co/ Hosted on Acast. See acast.com/privacy for more information.

My guest on the show today is Dr. Monnica T. Williams, certified licensed clinical psychologist and Associate Professor at the School of Psychology at the University of Ottawa. She received her undergraduate degree from M.I.T. in 1992 and she holds a Doctoral Degree in Clinical Psychology from the University of Virginia. Monnica is researching how PTSD symptoms can result from racism and what racial trauma and race-based trauma look like. Monnica also researches, partly in the context of MAPS, how to treat racial trauma with psychedelic-assisted therapy, such as with MDMA or Ketamine.I also talk to Monnica about diversity in the psychedelic science field, about the effects MDMA-assisted therapy can have on racial trauma, and what happens if your therapist might not be aware of their own racism. I think the questions we need to ask if it comes to the topic of race and mental health are quite endless. And we are only just starting. Hosted on Acast. See acast.com/privacy for more information.

We have a patient story on our hands today. And an athlete story. It is the story of Daniel Carcillo, who still goes under the Twitter -Name “CarBombBoom13” Daniel was known as “Car Bomb” during his NHL (National Hockey League) career because he played — and lived — with reckless abandon. According to his doctor, he also had seven diagnosed concussions. They contended that the NHL knowingly withheld information about the dangers of hockey-related brain injuries, actively promoted fighting and failed to assist players in the transition from the ice to everyday living.” writes the NYT. After suffering from depression, concussion and traumatic brain injury, Daniel tried everything, but nothing helped, his state of mind and body got worse. How does it feel, when your tried everything “under the sun”, as Daniel says. Finally, Daniel found someone, who gave him access to a so called hero dose, a very high dose, of psilocybin, which helped Daniel to come back to a life, his life. Now, Daniel wants to support the “traumatised community” he once came from, he is a plant medicine and fungi advocate. He is a farmer and entrepreneur with a fully integrated cannabis and medicinal mushroom business. Now, Daniel is the face of the decriminalise Chicago movement, talking about his journey with psychedelics, using them as a tool to heal. Hosted on Acast. See acast.com/privacy for more information.

Melissa Lavasani’s story in a nutshell: After suffering from a depression that nothing seemed to help, she finally learned about the potential of plant medicine (via a Podcast!) - but what would the other Moms at her children’s school say? Would she have to break the law to save herself? Well she made the choice to prioritise her mental health, and eventually started to thrive, which inspired her to become the force behind Decriminalise Washington - a political initiative helping decriminalise magic mushrooms and plant medicine so they can be used to treat depression.In the podcast, we talk about the so-called Baby Blues, which is the nice and easy word for postpartum depression and we talk about why becoming a mother is a full on identity crisis and can trigger things one never thought about. We talk about how a normal mum can be the best spokesperson for psychedelics and why it's good to convince as many republicans as possible, especially in the upcoming election, that psilocybin will help to save lives. Hosted on Acast. See acast.com/privacy for more information.

Brazil alert! My guest today is Dr. Bia Labate, a queer Brazilian anthropologist, ayahuasca expert, sociologist, author and cofounder of the Chacruna Institute. Bia Labate is one of the real experts in the field of plant medicine. And there is a lot to talk about, much more than just vomiting in a bucket, after drinking the psychedelic tea.When it comes to plant medicines, drug policy, shamanism, ritual, and religion, Bia is a pro and her Chacruna Institute is an organization that provides public education about psychedelic plant medicines and promotes a bridge between the ceremonial use of sacred plants and psychedelic science. Bia and I discuss Ayahuasca as a spiritual mentor, a teacher, a friend, as something that gives you homework to do with yourself and as something that is deeply rooted in South American culture. Bia has 23 years experience with Ayahuasca, a plant that gave her the feeling of “being at home for the first time”. We also talk about cultural appropriation and mindfulness towards the indigenous people, who are the ones providing the knowledge and the substances, diversity.https://chacruna.net/https://www.bialabate.net/ Hosted on Acast. See acast.com/privacy for more information.

https://maps.org/capstone https://tim.blog/2020/06/16/maps-capstone-challenge-mdma-ptsd/ Hosted on Acast. See acast.com/privacy for more information.

My guest Deborah Mash is one cool research lady from Miami. She’s tough, educated, and all-too familiar with the drug wars in Miami, a series of conflicts that took place between government and cartels during the ‘70s and ‘80s. She knew a Miami that was flooded with cocaine and champagne, resulting in mass addiction problems across society, and who are looking for new tools to beat addiction to this day. Mash is an American professor of neurology and pharmacology at the Leonard M. Miller School of Medicine, director of the Brain Endowment Bank at the University of Miami, and is the CEO of her company DemeRx.In the ‘90s, Mash and her team found a third substance that addicts produce if they use alcohol and cocaine at the same time, a molecule that makes addiction impossible to beat. Deborah called it the “Miami Vice Metabolite” and spent a lot of time researching how both the molecule and the resulting addiction could be handled.From very early on, Mash was an expert on heavy substance abuse, addiction that was destroying the many people’s lives. Now she’s researching Ibogaine, a natural indole alkaloid derived from the West African iboga plant. In African traditional medicine and rituals, chewing the yellow-coloured root or bark is used to produce hallucinations. Now, Mash and ATAI Life Sciences explore the ibogaine substance as a new mental health drug to beat alcohol, heroin and other opioid addiction. Hosted on Acast. See acast.com/privacy for more information.

I talk to Amanda Feilding, the “Countess of Psychedelics Science”, who you could say was somewhat of a psychedelic and scientific socialite in the sixties, and who has been a strong advocate behind the resurgence of psychedelic science and reform. Also known as Lady Neidpath and the Countess of Wemyss and March, she lives in Beckley Park, an estate just outside Oxford. Amanda’s contribution to global drug policy reform and early psychedelic research has been pivotal and widely acknowledged. She was first introduced to LSD in the mid-sixties, at the height of the first wave of scientific research into psychedelics. Impressed by its capacity to initiate mystical states of consciousness and heighten creativity, she quickly recognised its transformative and therapeutic powers. Today she is the owner of the Beckley Foundation, a UK-based think-tank and UN-accredited NGO, dedicated to activating global drug policy reform and initiating scientific research into psychoactive substances. Hosted on Acast. See acast.com/privacy for more information.

My guest on the show today is Amanda Eilian. Amanda is an investor, the co-founder of __able partners, together with Lisa Blau in New York City. Able Partners is an investment fund focused on supporting visionary, early stage brands in the positive living space. And yes, Amanda has invested in Gwyneth Paltrow’s GOOP empire. Listening to Amanda feels like you hear a flawless lecture on the current state of investment in psychedelics. But also on the reasons, why psychedelics are on the rise. One of them: our increased (and commercialised) search for wellness, is a sign of a heavily inadequate social system and so, at one point the wellness “classics” like yoga, mindfulness, talk therapy, extremely healthy eating and mediation apps seem not enough any more to help us through life: the effect certain societies and surroundings have on us, can’t be resolved with simple “wellness” and “mindfulness” bumper stickers any more. Amanda plays an important part in introducing psychedelics to the lifestyle and the new wellness world. The “New York Times” recently featured able partners in the article “The Capital That Ate Wellness Is Going to Eat Your Mushrooms . Venture capital arrives for psychedelics”Able partners are also focused on areas that have historical stigma often resulting in underserved markets, meaning that Amanda is investing in companies dealing with mental health or sexual wellness. In this episode, Amanda and I talk Covid19 times, the new era of mental health, and why there is a problem with our old idea of wellness. Hosted on Acast. See acast.com/privacy for more information.

German-born Gisela is also a photographer, film director, and author. She was part of the sixties and seventies bohemian milieu, mixing with the likes of Dennis Hopper, Hunter S. Thompson, Jack Nicholson, Leonard Cohen, and of course Timothy Leary, the controversial psychologist who researched LSD. But beyond all these job descriptions, Gisela is also a “lifelong seeker”. Gisela and her twin sister Jutta Winkelmann were highly involved in Germany’s “68 Movement”, but they always sought more, more than just belonging to a political movement. They wanted a meaningful life, rich with experience and trying everything that was available. Gisela then married John Paul Getty, they lived in California and they surrounded themselves with likeminded people who were also into new ideas and thinking about the world and humankind, which of course at that time, was heavily influenced by psychedelics. This meant that Gisela was around, when psychedelics became popularized in Western culture for the very first time, and also when the use of psychedelics was very much aligned with changing a whole society and the world. Hosted on Acast. See acast.com/privacy for more information.

Christian Angermayer is an entrepreneur, investor and a thriving force in the current psychedelic field. He is the founder of Apeiron Investment Group and the biotech company ATAI Life Sciences. ATAI’s focus is developing solutions to help the more than 300 million people globally who suffer from depression. Their research explores the use of psychedelic compounds to heal a broad range of mental health disorders alongside depression. This is Christian’s second appearance on the show. In this episode we really dive into his personal journey towards psychedelics and how he became a driving force in this exciting new industry. And we also talk about racial trauma, and the new ways we’re beginning to understand it and redefine our notions of mental health on a broader scale. Hosted on Acast. See acast.com/privacy for more information.

On today's podcast, I talk with JR Rahn, the CEO and Founder of MindMed. Their work involves creating transformative medicines to address big problems in society like anxiety, ADHD and addiction. They are achieving this through the use of psychedelic inspired medicines. Right now, MindMed is collaborating with the psychedelic research lab at the University of Basel and the University of Maastricht. JR and I discuss his journey from working at Uber to founding a leading psychedelic company which aims to create the “antibiotic for addiction”, as he says. We talk about JR’s investor Kevin O’Leary (Mr. Wonderful) from the TV Show Sharktank, and we discuss why prominent public figures like him could have a powerful impact on the de-stigmatisation of mental health and psychedelics. Hosted on Acast. See acast.com/privacy for more information.

Today, I talk to Rick Doblin, the Founder and Executive Director of MAPS (Multidisciplinary Association for Psychedelic Studies) A “non-profit research and educational organisation that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.” Some people say Rick is a “Mensch” and that’s yiddish for a a person of integrity and honour, which I would like to confirm 100% regarding Now, after decades of focused, strategic effort, MAPS has achieved securing FDA approval to conduct a Phase III study of a psychedelic drug – in this case MDMA – for treatment-resistant PTSD. Hosted on Acast. See acast.com/privacy for more information.

This week, my guest is coach Dr. Michael Franz. And he could be one of the coaches helping to create a new kind of company: the one for our future, Michael supports CEOs, Principals & Entrepreneurs and their teams creating “agreeable” futures as he says. What makes him a unique guest for the show? Well he is an executive coach, who is guiding business-oriented medical plant journeys for CEOs & Entrepreneurs - actually very established ones. Michael is interested in how psychedelics enable leaders and himself to be much more present, empathetic, courageous, innovative and impactful. Hosted on Acast. See acast.com/privacy for more information.

I talk to Robin Carhart Harris about an important tool of the future: psychedelics. Robin has the aura of your typical “cool scientist” and heads the Psychedelic Research Group within the Centre for Psychiatry at Imperial College London. He has designed a number of functional brain imaging studies with psilocybin, LSD, MDMA and DMT, plus a clinical trial of psilocybin for treatment resistant depression. Carhart-Harris is the first person in the UK to have legally administered doses of LSD to human volunteers since the Misuse of Drugs Act of 1971. He is passionate about finding proof, that we need new mental health drugs. Hosted on Acast. See acast.com/privacy for more information.

For the premier episode of the “Heal Soul!” series in colaboration with Dr. Bronner’s I speak with Michael Pollan, an American journalist who has written several articles and a book about the new psychedelic science in connection with addiction and depression, including “How to Change Your Mind”. During the interview, Pollan emphasizes that in his opinion psychedelics are wasted on the young and can be more useful later in life. He believes that psychedelic therapy will be available in Britain and the US within the next few years. For him it is greatly fascinating to have access to such a powerful tool to treat depression and post-traumatic stress disorder (PTSD). Hosted on Acast. See acast.com/privacy for more information.

Dr. Rosalind Watts is the clinical lead at “Imperial Centre for Psychedelic Research”, which is connected to the Imperial College in London. One of the most important psychedelic research centers right now.Rosalind’s Ted Talk “Can Magic Mushrooms unlock depression” was one of the first talks I have ever seen on the topic of psychedelics. I loved Rosalinds very human, very patient support driven approach to the topic of psychedelic therapy and treatment resistant depression. I also love that we had great laugh about, how she and her university friends lived above a magic mushrooms shop in Birmingham back then. But our talk is about the future of psychedelic therapy, about micro dosing and how it can make you cry, instead of being super focused on “work stuff” and if it is a good thing, that our "business as usual" is interrupted now. “Hunger for nature, spending time together and new experiences is what we are seeing right now. And psychedelic therapy can play a huge role in this.” says Watts. Hosted on Acast. See acast.com/privacy for more information.

We are going full entertainment and Netflix here! I talk to Donick Cary, the director of the Netflix movie called “Have a good trip”. Cary interviewed Sting, Deepak Chopra, Rosie Perez, Ben Stiller, Anthony Bourdain, Cary Fisher and Sarah Silverman about their psychedelic trips and how their lives and minds changed after their psychedelic experience. For good. Donick Cary gets the movie right, since he is a big shot Hollywood writer: he worked as the head writer at Late Night with David Letterman, he wrote for The Simpsons, Parks and Recreation, HBO’s Silicon Valley. Carys uses a specific kind of humour, since he is trained in his writing for the Simpsons and Letterman. So how do you talk psychedelics with celebrities and make it entertaining and not an ego driven trip bragging? And will celebrities talking about this change the public opinion about these new tools? Well, if humour is part of the equation, “people will listen” says Cary. Or, as Deepak Chopra says “Life a trip,” and psychedelics might help to improve your ride. Hosted on Acast. See acast.com/privacy for more information.

I talk to Zack Haigney the founder of the Trip Report, a cool, new newsletter on the Business, Policy and Impact of Psychedelics The Trip Report monitors the Business, Policy, Regulation, Science and Cultural Impact of Psychedelics and aims to be the go-to media outlet. Zach, not unlike myself, started to be involved in the psychedelic industry not that long ago and I like the way he is reporting and reflecting in his newsletter on all that is happening now so fast in the current psychedelic ecosystem. We talk how do to a good newsletter and if and why psychedelic can be political. One day. that’s what Zach and I agreed on, we will run a mantel wellness morning show. Hosted on Acast. See acast.com/privacy for more information.

I am talking to Ronan Levy from "Field Trip Health" based in Canada. The company is providing clinics for evidence based legal psychedelic therapies to treat depression. But what I like about "Field Trip Health" is their attitude towards a really dated idea to call some people “sick” or “crazy”. Field Trip Health says, we treat people, not patients. “We are all sick and healthy at the same time. It’s just that some people need more support.” says Ronan.We discuss the design places for a psychedelic treatment should have. Should they look more like a spa? Or a clinic? Or do we need new designs? And do the “ well" need psychedelics to get “better"? Or should we only focus on clinically depressed people? But then again, these concepts and terms don’t work any more. Join me and Ronan talking new psychedelic solutions and why mindfullness is not enough anymore. Hosted on Acast. See acast.com/privacy for more information.

A mental wellness philosopher, that is what I call Elise Loehnen. She is now the “chief content officer” at goop.com, the health company founded by Gwyneth Paltrow. She is in charge of the language that is used at Goop, especially if it comes to mental wellness and mental health. I think that Elise created a whole new language around mental wellness, especially in her Goop Podcast she cohosts with Gwyneth Paltrow: because we need a completely new language to address mental health. “Crazy” or “depressed” doesn’t do the job any more. Listen to Elise and me, exchanging Psilocybin-Experiences and trying to make sense of the current cultural PTSD during and after Covid19. Hosted on Acast. See acast.com/privacy for more information.